WO1992010225A1 - A two-compartment syringe assembly and a method of producing a two-compartment syringe assembly - Google Patents

A two-compartment syringe assembly and a method of producing a two-compartment syringe assembly Download PDF

Info

Publication number
WO1992010225A1
WO1992010225A1 PCT/DK1991/000380 DK9100380W WO9210225A1 WO 1992010225 A1 WO1992010225 A1 WO 1992010225A1 DK 9100380 W DK9100380 W DK 9100380W WO 9210225 A1 WO9210225 A1 WO 9210225A1
Authority
WO
WIPO (PCT)
Prior art keywords
cylindrical barrel
compartment
plunger
syringe assembly
barrel
Prior art date
Application number
PCT/DK1991/000380
Other languages
French (fr)
Inventor
Michael Morris
Original Assignee
Medinject A/S
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medinject A/S filed Critical Medinject A/S
Priority to US07/781,220 priority Critical patent/US5429603A/en
Publication of WO1992010225A1 publication Critical patent/WO1992010225A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/3145Filters incorporated in syringes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31596Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M2005/3123Details having air entrapping or venting means, e.g. purging channels in pistons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/31Details
    • A61M5/315Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms
    • A61M5/31596Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing
    • A61M2005/31598Pistons; Piston-rods; Guiding, blocking or restricting the movement of the rod or piston; Appliances on the rod for facilitating dosing ; Dosing mechanisms comprising means for injection of two or more media, e.g. by mixing having multiple telescopically sliding coaxial pistons encompassing volumes for components to be mixed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61MDEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M5/00Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
    • A61M5/178Syringes
    • A61M5/28Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle
    • A61M5/285Syringe ampoules or carpules, i.e. ampoules or carpules provided with a needle with sealing means to be broken or opened

Definitions

  • the present invention relates to a two-compartment syringe assembly for storing a liquid and a material, and for preparing a dilution of said material within said liquid prior to dispensing said liquid, and further to a method of producing a two-compartment syringe assembly for storing a liquid and a material and for preparing a dilution of said ma ⁇ terial within said liquid prior to dispensing said liquid.
  • a serious drawback of the two-compartment syringe assembly is due to the lack of providing a controllable venting of the two-compartment syringe assembly when the dilution is prepared, as some materials or me ⁇ dicaments when diluted in a liquid or in a solvent create aerosols and gases which have to be vented, however, have to be vented through fil- tering means in order to eliminate to any substantial extent the risk that the person, such as a doctor, a nurse, or a pharmacist, operating the two-compartment syringe assembly is exposed to hazardous, such as toxic or carcinogenic aerosols and gases.
  • a further drawback of the two-compartment syringe assembly origin ⁇ ates from the fact that the two-compartment syringe assembly in case it is exposed to shocks or blows or dropped on a floor may leak, causing an extremely hazardous situation in case the two-compartment syringe as- sembly is dropped, e.g. in a hospital.
  • An object of the present invention is to provide a two-compartment syringe assembly for storing a liquid and a material such as a powder medicament or an active liquid component and for preparing a dilution of the material within the liquid prior to dispensing the liquid from the two-compartment syringe assembly which syringe assembly provides a radi ⁇ cally improved protection of the staff producing the two-compartment sy ⁇ ringe assembly, handling the two-compartment syringe assembly while transferring the two-compartment syringe assembly from the manufacturing plant to the hospital and operating the two-compartment syringe assembly for preparing the dilution prior to dispensing the dilution of the mate ⁇ rial within the liquid, as the two-compartment syringe assembly provides a mechanical protection of the container in which the material is en- closed in a sealed compartment eliminating to any substantial extent the risk that the material, i.e. the active material, such as cytostatics
  • a particular feature of the two-compartment syringe assembly ori- ginates from the fact that the two-compartment syringe assembly is easi ⁇ ly constructed so as to provide a controlled venting of the two-com ⁇ partment syringe assembly by providing a separate venting channel in which a filtering means is enclosed, e.g. comprising activated carbon.
  • a particular advantage of the two-compartment syringe assembly ac- cording to the present invention relates to the provision of a separate sealed ampulla enclosing the material, such as the active liquid compo ⁇ nent or the medicament, e.g.
  • a cytostatic which ampulla is received within the two-compartment syringe assembly fulfilling the above object as the ampulla is concealed within the two-compartment syringe assembly and protected from being damaged by shocks or blows, e.g. in case the two-compartment syringe assembly is dropped.
  • a two-compartment syringe assembly for storing a liquid and a material and for preparing a dilution of the material within the liquid prior to dispensing the liquid, comprising: a first cylindrical barrel having a first cylindrical wall and de ⁇ fining a first and a second end of the first cylindrical barrel, a first compartment being defined within the first cylindrical barrel by the first cylindrical wall, the first end of the first cylindrical barrel constituting a dispensing end and the second end of the first cylin ⁇ drical barrel being open, a second cylindrical barrel having an outer cylindrical wall, an inner cylindrical wall, and an end wall and defining a first and a se- cond end of the second cylindrical barrel, the outer and inner cylin ⁇ drical walls being integrally connected through the end wall at the first end of the second cylindrical barrel, a second compartment being defined within the second cylindrical barrel by the
  • the risk of leakage from the second compartment containing the material to the atmosphere or en ⁇ vironment in case the two-compartment syringe assembly is exposed to shocks or blows is radically reduced as compared to the prior art two- compartment syringe assemblies in which the material is enclosed within the outer barrel of the structure, i.e. within the barrel corresponding to the first cylindrical barrel of the two-compartment syringe assembly according to the present invention.
  • any risk of evaporation of the liquid from the first com ⁇ partment, and consequently from the two-compartment syringe assembly ac ⁇ cording to the present invention to the environment is eliminated, and any risk of contamination of the liquid from the environment is also eliminated due to the enclosing of the liquid within the first com ⁇ partment of the two-compartment syringe assembly according to the pre ⁇ sent invention.
  • the plunger defines a venting passage extending through the plunger body, in which venting passage a filtering means is enclosed.
  • the filtering means preferably comprises a hydrophobic filter means, such as a foil or mem ⁇ brane of micropore polyurethane (PU), micropore polytetrafluoroethylene (PTFE), micropore polypropylene (PP), micropore polyethylene (PE), poly- tri ethylsilylpropylene or polydimethylsiloxane, a micropore fibre fil ⁇ ter, and an activated carbon filter body.
  • any hazardous, such as carcinogenic or toxic aerosols and/or gases produced as the material is diluted within the liquid is vented through the activated carbon filter body, and any risk of exposing the person, such as the doctor, the nurse, or the pharmacist operating the two-compartment syringe assembly, is to any substantial extent eliminated or at least radically reduced as compared to the prior art two-compartment syringe assemblies.
  • the filtering means enclosed within the plunger body of the plunger of the two-compartment syringe assembly according to the present inven ⁇ tion may in accordance with an alternative embodiment comprise a foil of a material which is soluble in the liquid contained within the first compartment of the two-compartment syringe assembly.
  • the soluble material may be polyvinyl alcohol of a foil of a thickness of e.g. 10-20 ⁇ m.
  • the liquid-soluble foil is preferably arranged as a first barrier of the filter means separating the remaining components of the filtering means, such as the hydrophobic filter means, the micropore fibre filter, and the activated carbon filter body from the first and second com ⁇ partment of the two-compartment syringe assembly.
  • the li- quid-soluble foil of the filter means provides a sealing membrane which consequently seals the second compartment relative to the environment which causes a compression of the air enclosed within the second com ⁇ partment as the plunger is further advanced, which increase in gas pres ⁇ sure within the second compartment as the plunger is further advanced eventually perforates or ruptures the rupturable seal at the first end of the second cylindrical barrel so as to allow the material to be dis ⁇ claimedd from the second compartment to the first compartment and so as to expose the liquid-soluble foil to the liquid for dissolving at least part of the liquid-soluble foil and for allowing that aerosols and/or gases are vented from the first compartment through the filtering means to the atmosphere.
  • the liquid is a non-aqueous liquid
  • a diffe ⁇ rent soluble foil material has to be provided.
  • the material has to be enclosed within the second compartment of the second cylindrical bar ⁇ rel in non-evacuated state, e.g. in a gas which is inert or inactive re- lative to the material, such as for most materials nitrogen, or an inert gas such as e.g. argon.
  • the two-com ⁇ partment syringe assembly preferably further comprises separate locking means for locking the first cylindrical barrel, the second cylindrical barrel, and the plunger in specific positions and for blocking the cy ⁇ lindrical barrels and the plunger from being disassembled.
  • the two-compartment syringe assembly preferably further comprises a first, breakable locking means for locking the plunger in the first, extracted position relative to the second cylin ⁇ drical barrel, however, allowing, when broken, that the plunger is dis- placed relative to the second cylindrical barrel from the first, ex ⁇ tracted position to the second, inserted position, and preferably further comprises a second locking means for locking the plunger in the second, inserted position relative to the second cylindrical barrel when displaced to the second, inserted position from the first, extracted po ⁇ sition and for preventing the plunger from being retracted from the se ⁇ cond, inserted position relative to the second cylindrical barrel.
  • the two-compartment syringe assembly pre ⁇ ferably further comprises a third, breakable locking means for locking the second cylindrical barrel in the third, extracted position relative to the first cylindrical barrel, however, allowing, when broken, that the second cylindrical barrel is displaced relative to the first cylin ⁇ drical barrel from the third, extracted position to the fourth position, and preferably further comprises a fourth locking means for locking the second cylindrical barrel in the fourth position relative to the first cylindrical barrel when displaced to the fourth position from the third, extracted position and for preventing the second cylindrical barrel from being retracted from the fourth position relative to the first cylindri ⁇ cal barrel .
  • the first and second cylindrical barrels and the plunger of the two-compartment syringe assembly according to the present invention may be made from any appropriate material, such as a thermoplastic material, e.g. polystyrene, polyi ide, polycarbonate, polymethacrylates, poly ⁇ vinylidenefluoride, polyamide, polyvinyl alcohol, and preferably polyo- lefines, such as low-density polyethylene (LDPE), medium-density poly ⁇ ethylene (MDPE), high-density polyethylene (HDPE), linear low-density polyethylene (LLDPE), polypropylene (PP), polypropylene-ethylene-copoly- mer, or any mixture thereof.
  • LDPE low-density polyethylene
  • MDPE medium-density poly ⁇ ethylene
  • HDPE high-density polyethylene
  • LLDPE linear low-density polyethylene
  • PP polypropylene
  • polypropylene-ethylene-copoly- mer or any mixture thereof.
  • the inner cylindrical wall of the second cylin- drical barrel may preferably be made from a material which has been sur ⁇ face-treated in order to provide barrier properties by electron-ray- treatment, corona-treatment, plasma-treatment, plasma-polymerisation or any other appropriate surface-treatment.
  • the ma ⁇ terial is in accordance with the presently preferred embodiment of the two-compartment syringe assembly according to the present invention con ⁇ tained in a separate capsule or ampulla which on the one hand may be ma- nufactured in a conventional production plant and on the other hand may easily be made from a matrial such as glass, which may stand exposure to active or aggressive materials such as cytostatics or the like.
  • the second cylindrical barrel is composed of an outer body part and a cap ⁇ sule part, the capsule part comprising the inner cylindrical wall and the rupturable seals, and the outer body part constituting a support structure having a central recess in which the capsule part is received.
  • the capsule part constitutes a prefilled, sterilized a - pulla
  • the capsule part preferably comprises a cylindrical glass tube having opposite ends in which the rupturable seals are fixated re ⁇ lative to the cylindrical glass tube.
  • the capsule part may be made from any other appropriate material, such as a plastic material, e.g. the thermoplastic materials mentioned above which may further be surface-treated as discussed above.
  • the rupturable seals of the second cylindrical barrel or, addition ⁇ ally or alternatively, of the separate capsule part of the second cy ⁇ lindrical barrel optionally constituting a prefilled, sterilized ampulla may be made from any appropriate resistent and gas-impermeable material, such as a foil of a thermoplastic material, e.g. a foil of LDPE, LLDPE, HDPE, HDPE, PP, PU, polyvinyl alcohol, polyimide, polyamide, polyvinyli- denefluoride, cellulose acetate, polyvinyl acetate, copolymers and la ⁇ minates thereof, a foil of aluminum, or a laminated multilayer combina ⁇ tion thereof.
  • a foil of a thermoplastic material e.g. a foil of LDPE, LLDPE, HDPE, HDPE, PP, PU, polyvinyl alcohol, polyimide, polyamide, polyvinyli- denefluoride, cellulose acetate, poly
  • the two-compartment syringe assembly may be used for storing and preparing any material such as a powdered or particulate material or a viscous material such as a liquid, which material is to be diluted in a liquid such as a solvent prior to dispensing the liquid having the mate ⁇ rial diluted therein from the two-compartment syringe assembly.
  • the ma- terial may be any organic or inorganic material to be stored in a sepa ⁇ rate compartment, i.e. within the second compartment of the second cy ⁇ lindrical barrel of the two-compartment syringe assembly according to the present invention.
  • the liquid may constitute any organic or inorganic liquid, such as a solvent, an alcoholic or aqueous solu ⁇ tion, a base, an acid, a saline or sugary solution or the like, or any combination thereof.
  • the material preferably constitutes a highly active or aggressive material, such as pharmaceuticals, e.g.
  • cy- tostatics anti-biotics, hormones, central nervous agents, vaccines, anti-dotes, anti-bodies, anti-allergic agents, anti-coagulants, analge ⁇ sics, aggressive solutions, such as acids, bases, electrolyte solutions, solvents, such as DMSO (dimethylenesulphoxide) or any other materials or medicaments to be stored in a separate container, e.g. in a non-aqueous environment or in a highly concentrated solution.
  • DMSO dimethylsulphoxide
  • the two-compartment syringe assembly ac- cording to the present invention preferably further comprises a first seal-breaking means provided at the first end of the second cylindrical barrel for breaking the rupturable seal at the first end of the second cylindrical barrel when the plunger is displaced axially relative to the second cylindrical barrel from the first, extracted position towards the second, inserted position and further preferably comprises a second seal-breaking means provided at the plunger body of the plunger for breaking the rupturable seal at the second end of the second cylindrical barrel when the plunger is displaced axially relative to the second cy ⁇ lindrical barrel from the first, extracted position towards the second, inserted position.
  • the first seal- breaking means may be constituted by a cutting means provided at the support structure for perforating the rupturable seal as the capsule part is displaced within the central recess of the outer body part from a fifth, retracted position in which the rupturable seal provided at the first end of the second cylindrical barrel is out of contact with the first seal-breaking means and into a sixth position in which the rup ⁇ turable seal provided at the first end of the second cylindrical barrel is brought into contact with the first seal-breaking means through im ⁇ pact from the plunger agitating the capsule part.
  • the present invention also relates to a method of producing a two- compartment syringe assembly for storing a liquid and a material and for preparing a dilution of the material within the liquid prior to dispens ⁇ ing the liquid, and more specifically a method of producing a two-com- partment syringe assembly according to the present invention.
  • the method according to the present invention comprises the steps of: providing a first cylindrical barrel having a first cylindrical wall and defining a first and a second end of the first cylindrical bar- rel, a first compartment being defined within the first cylindrical bar ⁇ rel by the first cylindrical wall, the first end of the first cylindri ⁇ cal barrel constituting a dispensing end and the second end of the first cylindrical barrel being open, providing a second cylindrical barrel having an outer cylindrical wall, an inner cylindrical wall, and an end wall and defining a first and a second end of the second cylindrical barrel, the outer and inner cylindrical walls being integrally connected through the end wall at the first end of the second cylindrical barrel, a second compartment being defined within the second cylindrical barrel by the inner cylindrical wall of the second cylindrical barrel and constituting a sealed com ⁇ partment sealed by rupturable seals provided at the first and second ends of the second cylindrical barrel, providing a plunger having a central plunger body and an outer pe ⁇ ripheral plunger wall circumferentially encircling the central plunge
  • the method according to the present invention is preferably imple- mented for producing the above-described, presently preferred embodiment of the two-compartment syringe assembly according to the present inven ⁇ tion, and consequently preferably comprises the introductory step of producing the second cylindrical barrel as a combination of an outer bo ⁇ dy part and a capsule part, the capsule part comprising the inner cy- lindrical wall and the rupturable seals, and the outer body part consti ⁇ tuting a support structure having a central r-ecess in which the capsule part is received, and of arranging the material enclosed within the cap ⁇ sule part.
  • Fig. 1 is an exploded and perspective view of a first, presently preferred embodiment of a two-compartment syringe assembly according to the present invention comprising a separate medicament-containing ampul ⁇ la
  • Figs, la and lb are perspective views of alternative embodiments of the medicament-containing ampulla to be used in the two-compartment sy ⁇ ringe assembly according to the present invention
  • Figs. 2-4 are schematic and sectional views of the first, presently preferred embodiment of the two-compartment syringe assembly according to the present invention illustrating separate steps of operating the two-compartment syringe assembly for preparing a dilution of a medica ⁇ ment contained within the two-compartment syringe assembly within a di ⁇ luting liquid or solvent also contained within the two-compartment sy- ringe assembly,
  • Fig. 5 is a schematic and sectional view corresponding to the view of Fig. 2 of a second, slightly modified embodiment of the two-com ⁇ partment syringe assembly according to the present invention
  • Fig 5a is a perspective view of a membrane-perforating or cutting means of the second embodiment of the two-compartment syringe assembly shown in Fig. 5,
  • Figs. 6a-6e are schematic views illustrating a method of filling the ampulla of the two-compartment syringe assembly according to the present invention.
  • Figs. 7a-7e are schematic views illustrating a method of filling and sealing the two-compartment syringe assembly according to the pre ⁇ sent invention.
  • a first, presently preferred embodiment of a two-com- partment syringe assembly for storing a liquid and a material, such as a medicament, and for preapring a dilution of the material or medicament within the liquid prior to dispensing the liquid from the two-compartment syringe assembly.
  • the two-compartment syringe assembly is in its entirety designated the reference numeral 10.
  • the two-compartment syringe assembly 10 is composed of a total of four sepa ⁇ rate components or parts, viz. a first or outer cylindrical barrel 12, a second or inner cylindrical barrel 14, a material or medicament-contain ⁇ ing ampulla 16, and a plunger 18.
  • the ampulla 16 is received within the second or inner cylindrical barrel 14, as will be described in greater details below.
  • the first cylindrical barrel 12 constitutes a main barrel of the two-compartment syringe assembly, in which barrel the diluting liquid is contained and in which barrel the process of preparing a dilution of the medicament within the diluting liquid is performed.
  • the liquid is shown in Fig. 2 and is designated the reference numeral 20.
  • the first cylindrical barrel 12 comprises a cylindrical wall 22 de ⁇ fining a first end or dispensing end 24 and an opposite, open end at which a circumferential flange 26 extends radially outwards from the cy ⁇ lindrical wall 22.
  • a spout or nozzle 28 is provided at the centre of the first end or dispensing end 24 .
  • a needle assembly 30 is mounted, comprising a fixation component 32 co-operating with the spout or nozzle 28, and an elongated needle 34 extending from the distal end of the fixation component 32.
  • the second or inner cylindrical barrel 14 constitutes a support structure in which the medicament-containing ampulla 16 is received.
  • the inner cylindrical barrel 14 basically comprises an outer cylindrical wall 40, an inner cylindrical wall 42 and an end wall 44 which is ar- ranged at a first end of the inner cylindrical barrel 14 interconnecting the outer and inner cylindrical walls 40 and 42, respectively.
  • the end wall 44 is provided with a central through-going hole 46 which is arranged in registration with an inner space defined within the inner cylindrical wall 42, in which inner space the ampulla 16 is re- ceived.
  • the ampulla 16 is, as is evident from Fig. 2, supported in a storage position within the inner space defined within the inner cylin ⁇ drical wall 42 and is restricted from moving axially within the inner space relative to the inner cylindrical barrel 14 by inwardly pro ⁇ truding, annular projections 48 and 50.
  • a cutter means 52 of an annular configuration and constituting a separate component received within and supported by the inner cylindri ⁇ cal barrel 14 is arranged recessed relative to the end wall 44 thereof at the central, through-going hole 46 serving the purpose of perforating the ampulla 16 as the ampulla is displaced axially beyond the inwardly protruding, annular projection 48, as will be described in greater de ⁇ tails below.
  • the end wall 44 defines a first end of the inner cylindri ⁇ cal barrel 14, the opposite, second end of which is open.
  • an out ⁇ wardly protruding, annular flange 36 is provided at the open, second end of the inner cylindrical barrel 14.
  • annular projections 54 and 56 extend, which annu ⁇ lar projections co-operate with a circumferential recess 38 provided at the inner surface of the cylindrical wall 22 of the outer cylindrical barrel 12 at the second, open end thereof.
  • the ampulla 16 basically comprises a cylindrical glass tube 60 ha ⁇ ving opposite first and second ends at which rupturable sealing mem ⁇ branes 62 and 64, respectively, are provided.
  • the material or medicament to be diluted within the liquid 20 and later on dispensed from the two-compartment syringe assembly 60 is enclosed.
  • Fig. la and Fig. lb disclose in greater details two alternative em ⁇ bodiments of the ampulla 16.
  • the alternative embodiments of the ampulla 16 shown in Fig. la and lb basically differ from one another and from the embodiment shown in Fig. 1 in that the rupturable sealing membranes shown in Fig. 1 and lb designated the reference numerals 62a and 62b, respectively, are provided with score lines for reducing the pressure or force required for perforating the ampulla.
  • the rupturable sealing membrane 62a is provided with a circumferential score line 68 defining a central, circular membrane seg ⁇ ment 70 which is easily, i.e. at low pressure or low force, separated from the rest of the ampulla 16 along the score line 68.
  • a total of six radially extending score lines are pro ⁇ vided extending from the centre of the rupturable, sealing membrane 62b to the circumferential score line 68.
  • One of the radially extending score lines is designated the reference numeral 72.
  • the ra ⁇ dial score lines 72 are more easily ruptured than the circumferential score line 68 shown in Fig. lb in order to eliminate any risk that sepa ⁇ rate membrane segments of the rupturable, sealing membrane 62b is sepa ⁇ rated from the ampulla 66 as the ampulla is perforated along the score lines 72.
  • the rupturable, sealing membranes provided at the oppo- site first and second end of the ampulla 16 may be of identical configu ⁇ ration or alternatively of different configuration.
  • one of the membranes, or both membranes may be provided with score lines, and the score lines of the two membranes may even be different from one another.
  • the plunger 18 basically constitutes a piston component relative to the inner cylindrical barrel 14 serving the main purpose of dispensing the material or medicament 66 from the ampulla 16 to the liquid 20 of the outer cylindrical barrel 12, as will be described in greater details below with reference to Fig. 3.
  • the plunger 18 comprises an outer peripheral plunger wall 80, a central plunger body 82, and an end wall 84.
  • the plunger body 82 extends beyond the outer peripheral rim of the outer peripheral plunger wall 80 at a first end of the plunger 18, whereas the end wall 84 is provided at an opposite, second end of the plunger interconnecting the outer peri ⁇ pheral plunger wall 80 and the plunger body 82.
  • a cutter means 86 is provided, which cutter means 86 basically corresponds to the cutter means 52 of the inner cy ⁇ lindrical barrel 14.
  • the plunger body 82 is of a basically hollow configuration and is at its upper end opposite to the cutter means 86 provided with a filter container 88.
  • a filtering means such as activated carbon is enclosed, as is evident from Figs. 2-4.
  • the activated carbon-filling of the innerspace defined within the plunger body 82 and the filter container 88 is designated the re ⁇ ference numeral 90.
  • a plug body 92 seals the interior of the plunger body 82 and the filter container 88, which plug body comprises a plane outer surface through which venting holes are provided.
  • One of the venting holes is designated the reference numeral 94.
  • through-going holes are provided, one of which is designated the reference numeral 96, and a plurality of through-going holes are also provided at a radial surface of the filter container 88, one of which is designated the reference numeral 98.
  • a hydrophobic filter such as a foil of micropore polyurethane or micropore polytetrafluorethylene, and optionally combined with a micro ⁇ pore fibre filter designated the reference numeral 100 in its entirety is also inserted within the inner space defined within the plunger body 82 at the lower end thereof, serving the purpose of blocking water and microparticles from being transmitted through the combined hydrophobic filter and micropore fibre filter 100 and further through the activated carbon-filling 90 to the environment from the innerspaces defined within the two-compartment syringe assembly 10 during the process of trans ⁇ ferring the material or medicament 66 from the ampulla 16 to the liquid 20 of the outer cylindrical barrel 12 and of preparing a dilution of the material or medicament in the liquid and thereupon of dispensing the di ⁇ lution from the two-compartment syringe assembly, as will be described in greater details with reference to Figs.
  • the plunger 18 is also provided with two outwardly pro- truding, annular projections 102 and 104 co-operating with a circum ⁇ ferential recess 106 of the inner surface of the outer cylindrical wall 40 of the inner cylindrical barrel 14.
  • Fig. 2 the two-compartment syringe assembly 10 is shown in a state ready for use.
  • the inner cylindrical barrel 14 is received within the outer cylindrical barrel 12 as the first end of the inner cylindrical barrel 14 is inserted through the second, open end of the outer cylindrical barrel 12 and is locked in an extracted position as the outwardly protruding, annular projection 54 is received within the recess 38, preventing the inner cylindrical barrel 14 from being re ⁇ tracted from the outer cylindrical barrel 12.
  • the dovetail-like engage ⁇ ment of the projection 54 within the recess 38 allows that the inner cylindrical barrel 14 may be advanced into the innerspace defined within the outer cylindrical barrel 12 in which the liquid 20 is en ⁇ closed.
  • the plunger 18 is also received with ⁇ in the inner cylindrical barrel 14 at the second, open end thereof and is fixated relative to the inner cylindrical barrel 14 as the outwardly protruding, annular projection 102 of the plunger 18 is received within the recess 1Q6 of the inner surface of the outer cylindrical wall 40 of the inner cylindrical barrel 14.
  • the dovetail-like engagement between the projection 102 and the recess 106 allows that the plunger 18 may be displaced into the inner space defined within the inner cylindrical bar- rel 14, however, is prevented from being retracted from the inner cy ⁇ lindrical barrel 14.
  • the plunger body 82 is in the state shown in Fig. 2 in registration with the inner space defined within the inner cylindrical wall 42 of the inner cylindrical barrel 14 and conse- quently in registration with the ampulla 16, however, arranged at a short distance from the rupturable sealing membrane 64 of the ampulla 16 which is locked in the position shown in Fig. 2 by means of the inwardly protruding, annular projections 48,50, as described above.
  • the material or medicament 66 enclosed within the ampulla 16 is transferred from the ampulla 16 to the liquid 20 contained within the outer cylindrical barrel 12 by pressing the plunger 18 downwardly into the inner cylindrical barrel 14 from the position or state shown in Fig. 2 to the position or state shown in Fig. 3.
  • the cutter means 86 perforates the rupturable sealing me - brane 64 and presses the entire ampulla 16 downwardly from its position shown in Fig. 2 to the position shown in Fig. 3, i.e.
  • the person operating the two- compartment syringe assembly 10 may monitor the preparation of the di ⁇ lution of the material or medicament within the liquid. Provided the di ⁇ lution is properly prepared, an injection may be performed by means of the two-compartment syringe assembly 10. It is to be emphasized that the outwardly protruding, annular pro ⁇ jection 104 of the outer peripheral plunger wall 80 of the plunger 18 locks within the recess 106 of the inner cylindrical surface of the outer cylindrical wall 40 of the inner cylindrical barrel 14 and pre ⁇ vents the plunger 18 from being retracted from the position shown in Fig. 3.
  • the liquid 20 having therein the material or medicament diluted is expelled or dispensed from the compartment de- fined within the outer cylindrical barrel 12 through the nozzle 28 and further through the elongated needle 34 of the needle assembly 30.
  • the excess air present above the surface of the liquid 20 shown in Fig. 3 is vented through the combined hydrophobic filter and micropore fibre fil- ter 100 and the activated carbon filling 90 to the atmosphere.
  • the outwardly protruding, annular projection 54 is disengaged from its engagement within the recess 38 allowing that the inner cylin- drical barrel 14 is displaced into the inner compartment defined within the outer cylindrical barrel 12.
  • the inner cylindrical barrel 14 is locked relative to the outer cylindrical barrel 12 as the outwardly protruding, annular projection 56 locks within the recess 38 of the inner surface of the cylindrical wall 22 of the outer cylindrical barrel 12 and prevents the inner cylindrical barrel 14 from being re ⁇ tracted from its position totally received within the inner compartment defined within the outer cylindrical barrel 12. Consequently, reuse of the two-compartment syringe assembly and separation of the inner cylin- drical barrel 14 from the outer cylindrical barrel is prevented. Simi ⁇ larly, the plunger 18 is blocked from being retracted from the inner cy ⁇ lindrical barrel 14 as discussed above and from being separated there ⁇ from.
  • a second embodiment of the two-compartment syringe as- sembly according to the present invention is shown, designated the re ⁇ ference numeral 110 in its entirety.
  • the second embodiment 110 of the two-compartment syringe assembly according to the present invention dif ⁇ fers from the first, presently preferred embodiment 10 of the two-com ⁇ partment syringe assembly according to the present invention discussed above with reference to Figs. 1-4 in that the cutter means 52 of the in ⁇ ner cylindrical barrel 14 and the cutter means 86 of the plunger 18 are substituted by perforating means of a different configuration.
  • the needle assembly 30 shown in Figs. 2-4 is omitted, as the outer cylindrical barrel 12 of the two-compartment syringe as- sembly 110 shown in Fig. 5 is provided with a connector for connecting the two-compartment syringe assembly to an infusion bottle or infusion set.
  • the connector comprises a central needle 112, which extends through the spout or nozzle 28 and is blocked at its outer, distal end in the state of storing the two-compartment syringe assembly and of preparing the dilution of the material or medicament 66 within the liquid 20 by means of a plug 114 which is biased outwardly by a helical coil 116.
  • the assembly comprising the needle 112, the plug 114, and the coil 116 is protected by a circumferential wall 118 of the outer cylindrical barrel 12.
  • a connector plug 122 of the infusion bottle is brought into contact with the needle 112 by forcing the plug 114 upwardly or rearwardly relative to the needle 112 against the biasing force generated by the helical coil 116.
  • the infusion bottle 120 is removed from the two-compartment syringe assembly 110 which is thereupon disposed and destructed, e.g. in a high-tempera ⁇ ture combustion oven of a hospital or the like.
  • the connector plug 122 seals the infusion bottle 120 as the needle 112 is retracted from the infusion bottle.
  • the plug 114 serves the additional purpose of blocking the outer end of the needle 112 as the infusion bottle 120 is removed from the two-compartment syringe assembly in order to prevent that a person ope ⁇ rating the two-compartment syringe assembly, such as a doctor, a nurse or a pharmacist unintentionally contacts the odd end of the needle 112, which might cause serious injuries to the person, as the material or me- dicament 66 is often extremely toxic or carcinogenic, as the material or medicament 66 may constitute a cytostatic, an antibiotic, a hormone, or a central nervous agent or the like.
  • the cutter means 52 shown in Figs. 1-4 is substituted by an open- able four-segment cutter 124 which is shown in greater details in Fig. 5a.
  • the four-segment cutter 124 comprises four separate, integrally cast segments, one of which is designated the reference numeral 126 which is provided with a sharp cutting edge 128 and is connected to an adjacent segment through a breakable material strip 130.
  • the four-segment cutter 124 functions as a collapsible cutter means as the cutting edges 128 of the separate segments 126 initially perforate the rupturable, sealing membrane 62 of the ampulla 16, as the ampulla 16 is forced downwardly into contact with the four-segment cutter 124, whereupon the four seg ⁇ ments 126 are mutually separated along the material strips 130 and caused to hinge at the base of the individual segment 126 at the wall of the bore 46, as the material or medicament 66 is forced outwardly from the ampulla 16.
  • the cutter means 86 shown in Figs. 1-4 of the plunger 18 is substi ⁇ tuted by a protruding tip 132 which is provided centrally at the end wall of the central plunger body 82 of the plunger 18.
  • the protruding tip 132 is c rcumferentially encircled by the through-going holes 96.
  • the ampulla 16 is in the second embodiment 110 of the two-com ⁇ partment syringe assembly according to the present invention shown in Fig. 5 maintained in a frictional surface contact established between the outer peripheral surface of the glass tube of the ampulla 16 and the inner cylindrical surface of the inner cylindrical wall 42 of the inner cylindrical barrel 14.
  • the annu ⁇ lar fixation ring 134 initially forces the ampulla 16 downwardly, as discussed above, into an end position in which the lower rim of the glass tube 6 of the ampulla 16 rests behind the recess defined behind the bore 46, and further advancement of the plunger 18 causes the plunger body 82 to be forced through the annular fixation ring 134 so as to force the protruding tip 132 of the central plunger body 82 into con- tact with the rupturable sealing membrane 64 of the ampulla 16 for per ⁇ forating the membrane and for forcing the material or medicament 66 con ⁇ tained within the ampulla 16 out from the compartment defined within the ampulla 16 and down into the liquid 20.
  • the plunger body 82 in the second embodi- ment 110 shown in Fig. 5, and also in the first embodiment 10 shown in Figs. 1-4 provides a close fit within the cyl ndrical glass tube of the ampulla 16 in order to, to any substantial extent, cause any material adhering to the inner surface of the glass tube 60 of the ampulla 16 to be forced out of the ampulla 16 as the plunger body 82 is urged into the ampulla 16.
  • Fig. 6a-6e a process of filling the ampulla 16 of the two-com ⁇ partment syringe assembly is shown.
  • the glass tube 60 is shown cut from a length of a glass tube.
  • the rupturable, sealing membrane 62 is applied to the first end of the glass tube 60, e.g. by welding or by glueing the mem ⁇ brane 62 to the lower end of the glass tube.
  • the material 66 is filled into the chamber or compart ⁇ ment defined within the glass tube 60 by means of a dispensing nozzle 142 in a predetermined exact amount, such as an amount of the order of 3-5 ml .
  • Fig. 6d the rupturable, sealing membrane 64 is applied to the opposite second end of the glass tube 60 for sealing the chamber or com- partment defined within the glass tube 60 of the ampulla 16.
  • the produc ⁇ tion steps carried out in accordance with Fig. 6c and Fig. 6d may be carried out in a sterilized, evacuated chamber, provided the material calls for such precautions.
  • the entire ampulla may be sterilized in a sterilizing chamber 140 shown in Fig. 6c by exposure to high-temperature treatment or high-frequency treatment, such as exposure to high-temperature steam, UV, IR or microwave radiation or the like.
  • Fig. 7a-7e a process of producing the two-compartment syringe assembly according to the present invention is shown.
  • the outer cylindrical barrel 12 and the inner cylindrical barrel 14 are as ⁇ muld by positioning the inner cylindrical barrel 14 in the extracted position or state shown in Figs. 1, 2, 3, and 5.
  • the liquid 20 which may constitute a solvent, such as an aqueous or alcoholic suspension of e.g. sugar, an acid, or a base, an electrolytic solution or the like, is dispensed from a dispensing nozzle 144 through the central passage defined within the inner cylindrical wall 40 of the inner cylindrical barrel 14.
  • a solvent such as an aqueous or alcoholic suspension of e.g. sugar, an acid, or a base, an electrolytic solution or the like
  • the sterilized ampulla 16 is introduced into the inner cylindrical barrel 14 through the upper open end thereof.
  • the plunger 18 is mounted as the lower first end of the plunger 18 is introduced through the upper, open end of the inner cy ⁇ lindrical barrel 14. The plunger is locked in the position or state shown in Figs. 1, 2, and 5.
  • the two-compartment syringe assembly may be sterilized, e.g. in the sterilizing chamber 140 shown in Fig. 6e.
  • the assembled two-compartment syringe assembly is encapsulated within a sealed plastic bag 160.
  • the plastic bag 160 and the two-compartment syringe assembly 110 contained within the sealed plastic bag may be sterilized, e.g. in the sterilizing chamber 140 shown in Fig. 6e, or in a different sterili ⁇ zing chamber or in accordance with a different sterilizing technique.
  • ampulla 16 may be integrated into the inner cylindrical barrel 14 of the two-compartment syringe assembly which, of course, calls for certain minor modifications of the above described processes of producing the ampulla and the two-compartment sy ⁇ ringe assembly.
  • the entire inner cylindrical barrel 14 is manufactured in accordance with the technique disclosed in Fig.
  • the membrane 62 is applied to the upper, second end of the inner cylindrical barrel for sealing the inner compartment defined within the inner cylindrical wall 40 of the inner cylindrical barrel 14.
  • step shown in Fig. 7a is deleted as the l quid or solvent is dispensed from the dispensing nozzle 144 into the inner com ⁇ partment defined within the outer cylindrical barrel 12 prior to the step of assembling the outer cylindrical barrel 12 and the inner cylin- drical barrel 14 integrally containing the material or medicament in the inner compartment defined within the inner cylindrical barrel 14.
  • the outer cylindrical barrel 12 was made from HDPE and had the fol ⁇ lowing dimensions.
  • the outer diameter of the cylindrical barrel was 35 mm
  • the inner diameter of the cylindrical barrel was 32 mm.
  • the inner height of the barrel was 60 mm.
  • the outer diameter of the circumferen ⁇ tial flange 26 was 55 mm
  • the thickness of the wall of the circumfe ⁇ rential flange 26 was 2 mm.
  • the inner cylindrical barrel 14 was made from HDPE and had the fol- lowing dimensions.
  • the overall length of the barrel was 78 mm
  • the outer diameter of the barrel was 32 mm
  • the inner diameter of the outer cy ⁇ lindrical wall of the barrel was 30 mm
  • the length of the inner cylin ⁇ drical wall was 60 mm.
  • the outer diameter of the inner cylindrical wall was 15 mm.
  • the inner diameter of the inner cylindrical wall was 13 mm.
  • the outer diameter of the annular flange was 38 mm.
  • the thickness of the wall of the annular flange was 2 mm.
  • the ampulla 16 was made from a cylindrical glass tube of an outer diameter of 13 mm and of a wall thickness of 1 mm.
  • the membranes were made from a laminated foil assembly comprising a 30 ⁇ m PE foil applied in contact with the rim of the glass tube and sealed thereto in a weld ⁇ ing process, and a 30 ⁇ m aluminum foil.
  • the welding process was carried out by means of a pressing tool heated to a temperature of the order of 150°C-200°C which generated an excess pressure of the order of 500 g - 1.5 kg for pressing the foil assembly towards the rim of the glass tube for a period of time of the order of 0.5-1 sec.
  • the welding process was carried out manually, during which welding process the adhesion of the laminated foil assembly to the rim of the glass tube was first tested to mechanical adherence and visually monitored.
  • the plunger 18 was made from HDPE.
  • the outer diameter of the outer peripheral plunger wall was 30 mm.
  • the wall thickness of the outer pe ⁇ ripheral plunger wall was .8 mm, the height of the outer peripheral plunger wall was 57 mm, and the end of the central plunger body was pro- truding 3.5 mm beyond the outer lower or opened end of the plunger.
  • the outer diameter of the plunger body was 12 mm.
  • the container of the plunger defined in the inner container had a diameter of 20 mm and a container height of 16 mm.
  • the plug sealing the filter container had corresponding dimensions and was integrally cast having a wall thickness of .8 mm.
  • the two-compartment syringe assembly was tested as the outer cy ⁇ lindrical barrel 12 was filled with water, and ampullas containing NaCl and dye Green S-E 142 were manufactured.
  • the rupturable sealing mem ⁇ branes of the individual ampulla were easily ruptured as the two-com- partment syringe assembly was operated as discussed above with reference to Figs. 2-4.
  • the inner cylindrical barrel and the plunger of the two-compartment syringe assembly may alternatively be cast in a two-step casting process in which the cylindrical walls of the inner cylindrical barrel and the plunger are cast from HDPE, whereupon in a second, integral casting step, 0-ring sealings are cast from a more elastic thermoplastic materi- al, such as LDPE or LLDPE substituting the outwardly protruding annular projections of the inner cylindrical barrel and the plunger.
  • a more elastic thermoplastic materi- al such as LDPE or LLDPE
  • the outer cylindrical barrel, the inner cylindrical barrel, and the plunger may be cast a thermo ⁇ plastic material, e.g. polystyrene, polyimide, polycarbonate, polymeth- acrylates, polyvinylidenefluoride, polyamide, polyvinyl alcohol, and preferably polyolefines, such as low-density polyethylene (LDPE), medi ⁇ um-density polyethylene (MDPE), high-density polyethylene (HDPE), linear low-density polyethylene (LLDPE), polypropylene (PP), polypropylene- ethylene-copolymer, or any mixture thereof.
  • LDPE low-density polyethylene
  • MDPE medi ⁇ um-density polyethylene
  • HDPE high-density polyethylene
  • LLDPE linear low-density polyethylene
  • PP polypropylene
  • polypropylene- ethylene-copolymer any mixture thereof.
  • the inner cylindrical wall of the inner cylindrical barrel may option- ally be plasma-coated in order to provide barrier properties by electron-ray-treatment, corona-treatment, plasma-treatment, plasma-poly ⁇ merisation or any other appropriate surface-treatment, for providing an integral ampulla of the inner cylindrical barrel of high-resistance, high-storage capability.
  • the rupturable sealing membranes may be made from aluminum, laminated aluminum, such as 30 ⁇ m aluminum, which is glued and/or welded to the rim of the inner compartment defined within the inner cylindrical barrel or defined by the glass tube of the ampul ⁇ la.
  • LDPE, PETP, or PU optionally covered by a laminated aluminum foil, such as 30 ⁇ m LDPE, 12 ⁇ m PETP, 12 ⁇ m Al, 80 ⁇ m LDPE, may be used.
  • Alternative laminated foil structures may be made from HIPS (high-impact polystyrene), PVOH (polyvinyl alcohol) constituting a 100% air-tight barrier in dry state, and HIPS, alternatively LDPE or PP, PVOH, and HIPS or PP, or further alternatively HDPE, PVOH, and HDPE.
  • HIPS high-impact polystyrene
  • PVOH polyvinyl alcohol
  • first embodiment of two-compartment syringe assembly 12 first or outer cylindrical barrel 5 14 second or inner cylindrical barrel
  • cylindrical wall 10 24 first end or dispensing end
  • cutter means 5 54 outwardly protruding annular projection
  • a two-compartment syringe assembly for storing a liquid and a material and for preparing a dilution of said material within said liqu ⁇ id prior to dispensing said liquid, comprising: a first cylindrical barrel having a first cylindrical wall and de ⁇ fining a first and a second end of said first cylindrical barrel, a first compartment being defined within said first cylindrical barrel by said first cylindrical wall, said first end of said first cylindrical barrel constituting a dispensing end and said second end of said first cylindrical barrel being open, a second cyl ndrical barrel having an outer cylindrical wall, an inner cylindrical wall, and an end wall and defining a first and a se- cond end of said second cylindrical barrel, said outer and inner cylin ⁇ drical walls being integrally connected through said end wall at said first end of said second cylindrical barrel, a second compartment being defined within said second cylindrical barrel by said inner cylindrical wall of said second cylindrical barrel and constituting a sealed com- partment sealed by rupturable seals provided at

Landscapes

  • Health & Medical Sciences (AREA)
  • Vascular Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Anesthesiology (AREA)
  • Biomedical Technology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Infusion, Injection, And Reservoir Apparatuses (AREA)

Abstract

A two-compartment syringe assembly (10) is composed of a first, outer cylindrical barrel (12), a second, inner cylindrical barrel (14) in which a material (66) is enclosed within a capsule part or ampulla (16) which is received and protected within the second cylindrical barrel, a plunger (18) and a liquid (20), which is enclosed within a first compartment defined within the first cylindrical barrel (12). As the material is concealed within the second cylindrical barrel, any risk of leakage of the material to the environment or atmosphere in case the two-compartment syringe assembly is exposed to shocks, such as mechanical blows, is radically reduced as compared to conventional two-compartment syringe assemblies. Furthermore, any toxic aerosols and gases generated as the material (66) is dispensed from the ampulla (16) to the first compartment containing the liquid (20) are vented through an activated carbon filling (90) of a central plunger body (82) of the plunger (18), which plunger body serves the purpose of dispensing the material (66) from the ampulla (16) as the two-compartment syringe assembly is operated.

Description

Title: A two-compartment syringe assembly and a method of producing a two-compartment syringe assembly.
The present invention relates to a two-compartment syringe assembly for storing a liquid and a material, and for preparing a dilution of said material within said liquid prior to dispensing said liquid, and further to a method of producing a two-compartment syringe assembly for storing a liquid and a material and for preparing a dilution of said ma¬ terial within said liquid prior to dispensing said liquid. From published European Patent Application, Publication No.
0397589, an apparatus for preparing a mixture of a solid, particulate or powdered component, and a liquid component, so as to provide a paste¬ like material therefrom is known, particularly for preparing acrylate bone cement. US Patent No. 4,910,259 describes an acrylate bone cement which is preferably used in the apparatus known from the published Euro¬ pean patent application.
The technique of storing two components such as a liquid or solvent and a material, such as a medicament constituting a solid or liquid com¬ ponent within separate containers or barrels of a so-called two-com- partment syringe prior to preparing a dilution of the material within the liquid is also well-known within the art. Reference is to be made to CH 622752, GB 1313339, GB 1413734, DE 2838222, W085/04567, WO 86/06618, FR 1164351, SE 378064, SE 464797, US 3,108,591, US, 3,570,486, US 3,685,514, US 4,254,768, US 4,306,554, US US 4,464,174, US 4,546,767, US 4,693,706, US 4,768,568, and US 4,886,495, and the above-listed US pa¬ tents are further incorporated in the present specification by referen¬ ce.
A representative example of the prior art two-compartment syringe assembly is disclosed in US Patent No. 3,685,514 which two-compartment syringe assembly is basically composed of two separate, conventional sy¬ ringes, one of which constitutes an inner syringe comprising an inner barrel and a plunger, which inner barrel contains the liquid or solvent. The inner barrel and plunger together constitute a plunger assembly of an outer syringe which further comprises an outer barrel containing the medicament. Among the above-listed references, elaborated structures comprising sealed capsules to be perforated and elaborated vents are disclosed. Common to the two-compartment syringe assemblies known within the art is the fact that the active material, i.e. the medicament or an ac¬ tive liquid component which is to be diluted within the liquid prior to dispensing from the two-compartment syringe assembly is contained within the outer barrel. A serious drawback of the two-compartment syringe assembly is due to the lack of providing a controllable venting of the two-compartment syringe assembly when the dilution is prepared, as some materials or me¬ dicaments when diluted in a liquid or in a solvent create aerosols and gases which have to be vented, however, have to be vented through fil- tering means in order to eliminate to any substantial extent the risk that the person, such as a doctor, a nurse, or a pharmacist, operating the two-compartment syringe assembly is exposed to hazardous, such as toxic or carcinogenic aerosols and gases.
Particularly when preparing cytostatics, serious problems have arisen, since hazardous, such as toxic or carcinogenic aerosols and gases are developed. Hitherto, attempts have been made as to solving these serious problems by prescribing that the person operating the two- compartment syringe assembly should use gloves, masks, specialized semi- closed mixing devices and carry out the mixing or preparation procedure in a fume cupboard with forced ventilation.
A further drawback of the two-compartment syringe assembly origin¬ ates from the fact that the two-compartment syringe assembly in case it is exposed to shocks or blows or dropped on a floor may leak, causing an extremely hazardous situation in case the two-compartment syringe as- sembly is dropped, e.g. in a hospital.
An object of the present invention is to provide a two-compartment syringe assembly for storing a liquid and a material such as a powder medicament or an active liquid component and for preparing a dilution of the material within the liquid prior to dispensing the liquid from the two-compartment syringe assembly which syringe assembly provides a radi¬ cally improved protection of the staff producing the two-compartment sy¬ ringe assembly, handling the two-compartment syringe assembly while transferring the two-compartment syringe assembly from the manufacturing plant to the hospital and operating the two-compartment syringe assembly for preparing the dilution prior to dispensing the dilution of the mate¬ rial within the liquid, as the two-compartment syringe assembly provides a mechanical protection of the container in which the material is en- closed in a sealed compartment eliminating to any substantial extent the risk that the material, i.e. the active material, such as cytostatics, leaks to the environment in case an outer component such as a wall of the two-compartment syringe assembly is broken.
A particular feature of the two-compartment syringe assembly ori- ginates from the fact that the two-compartment syringe assembly is easi¬ ly constructed so as to provide a controlled venting of the two-com¬ partment syringe assembly by providing a separate venting channel in which a filtering means is enclosed, e.g. comprising activated carbon. A particular advantage of the two-compartment syringe assembly ac- cording to the present invention relates to the provision of a separate sealed ampulla enclosing the material, such as the active liquid compo¬ nent or the medicament, e.g. a cytostatic, which ampulla is received within the two-compartment syringe assembly fulfilling the above object as the ampulla is concealed within the two-compartment syringe assembly and protected from being damaged by shocks or blows, e.g. in case the two-compartment syringe assembly is dropped.
The above object, the above feature, and the above advantage, to¬ gether with numerous other objects, features, and advantages are obtain¬ ed by means of a two-compartment syringe assembly for storing a liquid and a material and for preparing a dilution of the material within the liquid prior to dispensing the liquid, comprising: a first cylindrical barrel having a first cylindrical wall and de¬ fining a first and a second end of the first cylindrical barrel, a first compartment being defined within the first cylindrical barrel by the first cylindrical wall, the first end of the first cylindrical barrel constituting a dispensing end and the second end of the first cylin¬ drical barrel being open, a second cylindrical barrel having an outer cylindrical wall, an inner cylindrical wall, and an end wall and defining a first and a se- cond end of the second cylindrical barrel, the outer and inner cylin¬ drical walls being integrally connected through the end wall at the first end of the second cylindrical barrel, a second compartment being defined within the second cylindrical barrel by the inner cylindrical wall of the second cylindrical barrel and constituting a sealed com¬ partment sealed by rupturable seals provided at the first and second ends of the second cylindrical barrel, a plunger having a central plunger body and an outer peripheral plunger wall circumferentially encircling the central plunger body, the liquid being received within the first compartment of the first cylindrical barrel, and the material being enclosed within the second compartment of the second cylindrical barrel, the plunger being inserted into the second cylindrical barrel through the second end thereof, having its plunger body registered re¬ lative to the inner cylindrical wall of the second cylindrical barrel, and having its outer peripheral plunger wall received within the outer cylindrical wall of the second cylindrical barrel, the plunger being axially displaceable relative to the second cy¬ lindrical barrel from a first, extracted position to a second, inserted position in which the plunger body of the plunger is inserted into the second compartment of the second cylindrical barrel through the second end thereof, having ruptured the rupturable seals at the first and se- cond ends of the second cyl ndrical barrel, and establishes a sealing relationship with the inner cylindrical wall of the second cylindrical barrel, so as to allow the material to be dispensed from the second com¬ partment to the first compartment for being diluted within the liquid, the second cylindrical barrel being inserted into the first cy- lindrical barrel through the second end thereof, having its first end received within the first compartment, the second cylindrical barrel being axially displaceable relative to the first cylindrical barrel in sealing relationship therewith from a third, extracted position to a fourth position in which the first co - partment is substantially diminished and the liquid is dispensed from the first cylindrical barrel through the first end thereof.
As the material is enclosed within the second compartment of the second cylindrical barrel, i.e. enclosed within the inner cylindrical wall of the second cylindrical barrel concealed behind the outer cylin- drical wall of the second cylindrical barrel, the risk of leakage from the second compartment containing the material to the atmosphere or en¬ vironment in case the two-compartment syringe assembly is exposed to shocks or blows, is radically reduced as compared to the prior art two- compartment syringe assemblies in which the material is enclosed within the outer barrel of the structure, i.e. within the barrel corresponding to the first cylindrical barrel of the two-compartment syringe assembly according to the present invention. Furthermore, as the liquid is received within the first compartment of the first cylindrical barrel and enclosed within the first com¬ partment, any risk of evaporation of the liquid from the first com¬ partment, and consequently from the two-compartment syringe assembly ac¬ cording to the present invention to the environment is eliminated, and any risk of contamination of the liquid from the environment is also eliminated due to the enclosing of the liquid within the first com¬ partment of the two-compartment syringe assembly according to the pre¬ sent invention.
According to the presently preferred embodiment of the two-com- partment syringe assembly acccording to the present invention, the plunger defines a venting passage extending through the plunger body, in which venting passage a filtering means is enclosed. The filtering means preferably comprises a hydrophobic filter means, such as a foil or mem¬ brane of micropore polyurethane (PU), micropore polytetrafluoroethylene (PTFE), micropore polypropylene (PP), micropore polyethylene (PE), poly- tri ethylsilylpropylene or polydimethylsiloxane, a micropore fibre fil¬ ter, and an activated carbon filter body. Thus, any hazardous, such as carcinogenic or toxic aerosols and/or gases produced as the material is diluted within the liquid is vented through the activated carbon filter body, and any risk of exposing the person, such as the doctor, the nurse, or the pharmacist operating the two-compartment syringe assembly, is to any substantial extent eliminated or at least radically reduced as compared to the prior art two-compartment syringe assemblies.
The filtering means enclosed within the plunger body of the plunger of the two-compartment syringe assembly according to the present inven¬ tion may in accordance with an alternative embodiment comprise a foil of a material which is soluble in the liquid contained within the first compartment of the two-compartment syringe assembly. Thus, provided the liquid contains water, e.g. in an aqueous solution of NaCl , the soluble material may be polyvinyl alcohol of a foil of a thickness of e.g. 10-20 μm. The liquid-soluble foil is preferably arranged as a first barrier of the filter means separating the remaining components of the filtering means, such as the hydrophobic filter means, the micropore fibre filter, and the activated carbon filter body from the first and second com¬ partment of the two-compartment syringe assembly. By providing a liquid- soluble foil, the rupturable seals provided at the first and second ends of the second cylindrical barrel is easily perforated as the second rup- turable seal is first perforated as the plunger is advanced from its first, extracted position relative to the second cylindrical barrel of the two-compartment syringe assembly towards the second, inserted posi¬ tion relative to the second cylindrical barrel of the two-compartment syringe assembly. After the second rupturable seal is ruptured, the li- quid-soluble foil of the filter means provides a sealing membrane which consequently seals the second compartment relative to the environment which causes a compression of the air enclosed within the second com¬ partment as the plunger is further advanced, which increase in gas pres¬ sure within the second compartment as the plunger is further advanced eventually perforates or ruptures the rupturable seal at the first end of the second cylindrical barrel so as to allow the material to be dis¬ pensed from the second compartment to the first compartment and so as to expose the liquid-soluble foil to the liquid for dissolving at least part of the liquid-soluble foil and for allowing that aerosols and/or gases are vented from the first compartment through the filtering means to the atmosphere. Provided the liquid is a non-aqueous liquid, a diffe¬ rent soluble foil material has to be provided. Also, the material has to be enclosed within the second compartment of the second cylindrical bar¬ rel in non-evacuated state, e.g. in a gas which is inert or inactive re- lative to the material, such as for most materials nitrogen, or an inert gas such as e.g. argon.
In order to guarantee that the two-compartment syringe assembly is not disassembled, e.g. prior to the preparation of the dilution of the material within the liquid or after the preparation and after the dis- pensing of the liquid containing the material dilution, the two-com¬ partment syringe assembly preferably further comprises separate locking means for locking the first cylindrical barrel, the second cylindrical barrel, and the plunger in specific positions and for blocking the cy¬ lindrical barrels and the plunger from being disassembled. More specifically, the two-compartment syringe assembly preferably further comprises a first, breakable locking means for locking the plunger in the first, extracted position relative to the second cylin¬ drical barrel, however, allowing, when broken, that the plunger is dis- placed relative to the second cylindrical barrel from the first, ex¬ tracted position to the second, inserted position, and preferably further comprises a second locking means for locking the plunger in the second, inserted position relative to the second cylindrical barrel when displaced to the second, inserted position from the first, extracted po¬ sition and for preventing the plunger from being retracted from the se¬ cond, inserted position relative to the second cylindrical barrel. The two-compartment syringe assembly according to the present invention pre¬ ferably further comprises a third, breakable locking means for locking the second cylindrical barrel in the third, extracted position relative to the first cylindrical barrel, however, allowing, when broken, that the second cylindrical barrel is displaced relative to the first cylin¬ drical barrel from the third, extracted position to the fourth position, and preferably further comprises a fourth locking means for locking the second cylindrical barrel in the fourth position relative to the first cylindrical barrel when displaced to the fourth position from the third, extracted position and for preventing the second cylindrical barrel from being retracted from the fourth position relative to the first cylindri¬ cal barrel . The first and second cylindrical barrels and the plunger of the two-compartment syringe assembly according to the present invention may be made from any appropriate material, such as a thermoplastic material, e.g. polystyrene, polyi ide, polycarbonate, polymethacrylates, poly¬ vinylidenefluoride, polyamide, polyvinyl alcohol, and preferably polyo- lefines, such as low-density polyethylene (LDPE), medium-density poly¬ ethylene (MDPE), high-density polyethylene (HDPE), linear low-density polyethylene (LLDPE), polypropylene (PP), polypropylene-ethylene-copoly- mer, or any mixture thereof.
Provided the material contained within the second compartment de- fined within the second cylindrical barrel by the inner cylindrical wall thereof is an aggressive material which may decompose or degrade the ma¬ terial of the inner cylindrical wall of the second cylindrical barrel, e.g. provided the second cylindrical barrel is made from one of the above-listed materials, the inner cylindrical wall of the second cylin- drical barrel may preferably be made from a material which has been sur¬ face-treated in order to provide barrier properties by electron-ray- treatment, corona-treatment, plasma-treatment, plasma-polymerisation or any other appropriate surface-treatment. According to a particular feature of the present invention, the ma¬ terial is in accordance with the presently preferred embodiment of the two-compartment syringe assembly according to the present invention con¬ tained in a separate capsule or ampulla which on the one hand may be ma- nufactured in a conventional production plant and on the other hand may easily be made from a matrial such as glass, which may stand exposure to active or aggressive materials such as cytostatics or the like. Conse¬ quently, in accordance with the presently preferred embodiment of the two-compartment syringe assembly according to the present invention, the second cylindrical barrel is composed of an outer body part and a cap¬ sule part, the capsule part comprising the inner cylindrical wall and the rupturable seals, and the outer body part constituting a support structure having a central recess in which the capsule part is received. Advantageously, the capsule part constitutes a prefilled, sterilized a - pulla, and the capsule part preferably comprises a cylindrical glass tube having opposite ends in which the rupturable seals are fixated re¬ lative to the cylindrical glass tube. However, the capsule part may be made from any other appropriate material, such as a plastic material, e.g. the thermoplastic materials mentioned above which may further be surface-treated as discussed above.
The rupturable seals of the second cylindrical barrel or, addition¬ ally or alternatively, of the separate capsule part of the second cy¬ lindrical barrel optionally constituting a prefilled, sterilized ampulla may be made from any appropriate resistent and gas-impermeable material, such as a foil of a thermoplastic material, e.g. a foil of LDPE, LLDPE, HDPE, HDPE, PP, PU, polyvinyl alcohol, polyimide, polyamide, polyvinyli- denefluoride, cellulose acetate, polyvinyl acetate, copolymers and la¬ minates thereof, a foil of aluminum, or a laminated multilayer combina¬ tion thereof. The two-compartment syringe assembly may be used for storing and preparing any material such as a powdered or particulate material or a viscous material such as a liquid, which material is to be diluted in a liquid such as a solvent prior to dispensing the liquid having the mate¬ rial diluted therein from the two-compartment syringe assembly. The ma- terial may be any organic or inorganic material to be stored in a sepa¬ rate compartment, i.e. within the second compartment of the second cy¬ lindrical barrel of the two-compartment syringe assembly according to the present invention. Similarly, the liquid may constitute any organic or inorganic liquid, such as a solvent, an alcoholic or aqueous solu¬ tion, a base, an acid, a saline or sugary solution or the like, or any combination thereof. The material, however, preferably constitutes a highly active or aggressive material, such as pharmaceuticals, e.g. cy- tostatics, anti-biotics, hormones, central nervous agents, vaccines, anti-dotes, anti-bodies, anti-allergic agents, anti-coagulants, analge¬ sics, aggressive solutions, such as acids, bases, electrolyte solutions, solvents, such as DMSO (dimethylenesulphoxide) or any other materials or medicaments to be stored in a separate container, e.g. in a non-aqueous environment or in a highly concentrated solution.
In order to render it more easy for the person operating the two- compartment syringe assembly according to the present invention to per¬ forate the rupturable seals of the second cylindrical barrel of the two- compartment syringe assembly, the two-compartment syringe assembly ac- cording to the present invention preferably further comprises a first seal-breaking means provided at the first end of the second cylindrical barrel for breaking the rupturable seal at the first end of the second cylindrical barrel when the plunger is displaced axially relative to the second cylindrical barrel from the first, extracted position towards the second, inserted position and further preferably comprises a second seal-breaking means provided at the plunger body of the plunger for breaking the rupturable seal at the second end of the second cylindrical barrel when the plunger is displaced axially relative to the second cy¬ lindrical barrel from the first, extracted position towards the second, inserted position.
Provided the second cylindrical barrel of the two-compartment sy¬ ringe assembly according to the present invention is implemented in ac¬ cordance with the above-described, presently preferred embodiment as a composition of an outer body part and a capsule part, the first seal- breaking means may be constituted by a cutting means provided at the support structure for perforating the rupturable seal as the capsule part is displaced within the central recess of the outer body part from a fifth, retracted position in which the rupturable seal provided at the first end of the second cylindrical barrel is out of contact with the first seal-breaking means and into a sixth position in which the rup¬ turable seal provided at the first end of the second cylindrical barrel is brought into contact with the first seal-breaking means through im¬ pact from the plunger agitating the capsule part. The present invention also relates to a method of producing a two- compartment syringe assembly for storing a liquid and a material and for preparing a dilution of the material within the liquid prior to dispens¬ ing the liquid, and more specifically a method of producing a two-com- partment syringe assembly according to the present invention. Conse¬ quently, the method according to the present invention comprises the steps of: providing a first cylindrical barrel having a first cylindrical wall and defining a first and a second end of the first cylindrical bar- rel, a first compartment being defined within the first cylindrical bar¬ rel by the first cylindrical wall, the first end of the first cylindri¬ cal barrel constituting a dispensing end and the second end of the first cylindrical barrel being open, providing a second cylindrical barrel having an outer cylindrical wall, an inner cylindrical wall, and an end wall and defining a first and a second end of the second cylindrical barrel, the outer and inner cylindrical walls being integrally connected through the end wall at the first end of the second cylindrical barrel, a second compartment being defined within the second cylindrical barrel by the inner cylindrical wall of the second cylindrical barrel and constituting a sealed com¬ partment sealed by rupturable seals provided at the first and second ends of the second cylindrical barrel, providing a plunger having a central plunger body and an outer pe¬ ripheral plunger wall circumferentially encircling the central plunger body, arranging the liquid being received within the first compartment of the first cylindrical barrel, arranging the material being enclosed within the second compartment of the second cylindrical barrel, inserting the plunger into the second cylindrical barrel through the second end thereof, having its plunger body registered relative to the inner cylindrical wall of the second cylindrical barrel, and having its outer peripheral plunger wall received within the outer cylindrical wall of the second cylindrical barrel, so that the plunger is axially displaceable relative to the second cylindrical barrel from a first, ex¬ tracted position to a second, inserted position in which the plunger bo¬ dy of the plunger is inserted into the second compartment of the second cylindrical barrel through the second end thereof, having ruptured the rupturable seals at the first and second ends of the second cylindrical barrel, and establishes a sealing relationship with the inner cylindri¬ cal wall of the second cylindrical barrel, so as to allow the material to be dispensed from the second compartment to the first compartment for being diluted within the liquid, and inserting the second cylindrical barrel into the first cylindrical barrel through the second end thereof, having its first end received within the first compartment, so that the second cylindrical barrel is axially displaceable relative to the first cylindrical barrel in sealing relationship therewith from a third, extracted position to a fourth po¬ sition in which the first compartment is substantially diminished and liquid is dispensed from the first cylindrical barrel through the first end thereof.
The method according to the present invention is preferably imple- mented for producing the above-described, presently preferred embodiment of the two-compartment syringe assembly according to the present inven¬ tion, and consequently preferably comprises the introductory step of producing the second cylindrical barrel as a combination of an outer bo¬ dy part and a capsule part, the capsule part comprising the inner cy- lindrical wall and the rupturable seals, and the outer body part consti¬ tuting a support structure having a central r-ecess in which the capsule part is received, and of arranging the material enclosed within the cap¬ sule part.
The present invention will now be further described with reference to the drawings, in which
Fig. 1 is an exploded and perspective view of a first, presently preferred embodiment of a two-compartment syringe assembly according to the present invention comprising a separate medicament-containing ampul¬ la, Figs, la and lb are perspective views of alternative embodiments of the medicament-containing ampulla to be used in the two-compartment sy¬ ringe assembly according to the present invention,
Figs. 2-4 are schematic and sectional views of the first, presently preferred embodiment of the two-compartment syringe assembly according to the present invention illustrating separate steps of operating the two-compartment syringe assembly for preparing a dilution of a medica¬ ment contained within the two-compartment syringe assembly within a di¬ luting liquid or solvent also contained within the two-compartment sy- ringe assembly,
Fig. 5 is a schematic and sectional view corresponding to the view of Fig. 2 of a second, slightly modified embodiment of the two-com¬ partment syringe assembly according to the present invention, Fig 5a is a perspective view of a membrane-perforating or cutting means of the second embodiment of the two-compartment syringe assembly shown in Fig. 5,
Figs. 6a-6e are schematic views illustrating a method of filling the ampulla of the two-compartment syringe assembly according to the present invention, and
Figs. 7a-7e are schematic views illustrating a method of filling and sealing the two-compartment syringe assembly according to the pre¬ sent invention.
In Figs. 1-4, a first, presently preferred embodiment of a two-com- partment syringe assembly is shown for storing a liquid and a material, such as a medicament, and for preapring a dilution of the material or medicament within the liquid prior to dispensing the liquid from the two-compartment syringe assembly. The two-compartment syringe assembly is in its entirety designated the reference numeral 10. Basically, the two-compartment syringe assembly 10 is composed of a total of four sepa¬ rate components or parts, viz. a first or outer cylindrical barrel 12, a second or inner cylindrical barrel 14, a material or medicament-contain¬ ing ampulla 16, and a plunger 18. The ampulla 16 is received within the second or inner cylindrical barrel 14, as will be described in greater details below.
The first cylindrical barrel 12 constitutes a main barrel of the two-compartment syringe assembly, in which barrel the diluting liquid is contained and in which barrel the process of preparing a dilution of the medicament within the diluting liquid is performed. The liquid is shown in Fig. 2 and is designated the reference numeral 20.
The first cylindrical barrel 12 comprises a cylindrical wall 22 de¬ fining a first end or dispensing end 24 and an opposite, open end at which a circumferential flange 26 extends radially outwards from the cy¬ lindrical wall 22. At the centre of the first end or dispensing end 24, a spout or nozzle 28 is provided. At the spout or nozzle 28, a needle assembly 30 is mounted, comprising a fixation component 32 co-operating with the spout or nozzle 28, and an elongated needle 34 extending from the distal end of the fixation component 32. The second or inner cylindrical barrel 14 constitutes a support structure in which the medicament-containing ampulla 16 is received. The inner cylindrical barrel 14 basically comprises an outer cylindrical wall 40, an inner cylindrical wall 42 and an end wall 44 which is ar- ranged at a first end of the inner cylindrical barrel 14 interconnecting the outer and inner cylindrical walls 40 and 42, respectively.
The end wall 44 is provided with a central through-going hole 46 which is arranged in registration with an inner space defined within the inner cylindrical wall 42, in which inner space the ampulla 16 is re- ceived. The ampulla 16 is, as is evident from Fig. 2, supported in a storage position within the inner space defined within the inner cylin¬ drical wall 42 and is restricted from moving axially within the inner space relative to the inner cylindrical barrel 14 by inwardly pro¬ truding, annular projections 48 and 50. A cutter means 52 of an annular configuration and constituting a separate component received within and supported by the inner cylindri¬ cal barrel 14 is arranged recessed relative to the end wall 44 thereof at the central, through-going hole 46 serving the purpose of perforating the ampulla 16 as the ampulla is displaced axially beyond the inwardly protruding, annular projection 48, as will be described in greater de¬ tails below. The end wall 44 defines a first end of the inner cylindri¬ cal barrel 14, the opposite, second end of which is open.
At the open, second end of the inner cylindrical barrel 14, an out¬ wardly protruding, annular flange 36 is provided. From the outer surface of the outer cylindrical wall 40 of the inner cylindrical barrel 14, two outwardly protruding, annular projections 54 and 56 extend, which annu¬ lar projections co-operate with a circumferential recess 38 provided at the inner surface of the cylindrical wall 22 of the outer cylindrical barrel 12 at the second, open end thereof. The ampulla 16 basically comprises a cylindrical glass tube 60 ha¬ ving opposite first and second ends at which rupturable sealing mem¬ branes 62 and 64, respectively, are provided. Within the sealed inner compartment defined within the cylindrical glass tube 60 of the ampulla 16, the material or medicament to be diluted within the liquid 20 and later on dispensed from the two-compartment syringe assembly 60 is enclosed.
Fig. la and Fig. lb disclose in greater details two alternative em¬ bodiments of the ampulla 16. The alternative embodiments of the ampulla 16 shown in Fig. la and lb basically differ from one another and from the embodiment shown in Fig. 1 in that the rupturable sealing membranes shown in Fig. 1 and lb designated the reference numerals 62a and 62b, respectively, are provided with score lines for reducing the pressure or force required for perforating the ampulla.
In Fig. la, the rupturable sealing membrane 62a is provided with a circumferential score line 68 defining a central, circular membrane seg¬ ment 70 which is easily, i.e. at low pressure or low force, separated from the rest of the ampulla 16 along the score line 68. In Fig. lb, a total of six radially extending score lines are pro¬ vided extending from the centre of the rupturable, sealing membrane 62b to the circumferential score line 68. One of the radially extending score lines is designated the reference numeral 72. Preferably, the ra¬ dial score lines 72 are more easily ruptured than the circumferential score line 68 shown in Fig. lb in order to eliminate any risk that sepa¬ rate membrane segments of the rupturable, sealing membrane 62b is sepa¬ rated from the ampulla 66 as the ampulla is perforated along the score lines 72.
Obviously, the rupturable, sealing membranes provided at the oppo- site first and second end of the ampulla 16 may be of identical configu¬ ration or alternatively of different configuration. Thus, one of the membranes, or both membranes, may be provided with score lines, and the score lines of the two membranes may even be different from one another. The plunger 18 basically constitutes a piston component relative to the inner cylindrical barrel 14 serving the main purpose of dispensing the material or medicament 66 from the ampulla 16 to the liquid 20 of the outer cylindrical barrel 12, as will be described in greater details below with reference to Fig. 3.
The plunger 18 comprises an outer peripheral plunger wall 80, a central plunger body 82, and an end wall 84. The plunger body 82 extends beyond the outer peripheral rim of the outer peripheral plunger wall 80 at a first end of the plunger 18, whereas the end wall 84 is provided at an opposite, second end of the plunger interconnecting the outer peri¬ pheral plunger wall 80 and the plunger body 82. At the outer, exposed end of the plunger body 82, a cutter means 86 is provided, which cutter means 86 basically corresponds to the cutter means 52 of the inner cy¬ lindrical barrel 14.
The plunger body 82 is of a basically hollow configuration and is at its upper end opposite to the cutter means 86 provided with a filter container 88. Within the plunger body 82 and the filter container 88, a filtering means such as activated carbon is enclosed, as is evident from Figs. 2-4. The activated carbon-filling of the innerspace defined within the plunger body 82 and the filter container 88 is designated the re¬ ference numeral 90.
A plug body 92 seals the interior of the plunger body 82 and the filter container 88, which plug body comprises a plane outer surface through which venting holes are provided. One of the venting holes is designated the reference numeral 94. At the lower end of the plunger bo¬ dy 82, through-going holes are provided, one of which is designated the reference numeral 96, and a plurality of through-going holes are also provided at a radial surface of the filter container 88, one of which is designated the reference numeral 98. A hydrophobic filter, such as a foil of micropore polyurethane or micropore polytetrafluorethylene, and optionally combined with a micro¬ pore fibre filter designated the reference numeral 100 in its entirety is also inserted within the inner space defined within the plunger body 82 at the lower end thereof, serving the purpose of blocking water and microparticles from being transmitted through the combined hydrophobic filter and micropore fibre filter 100 and further through the activated carbon-filling 90 to the environment from the innerspaces defined within the two-compartment syringe assembly 10 during the process of trans¬ ferring the material or medicament 66 from the ampulla 16 to the liquid 20 of the outer cylindrical barrel 12 and of preparing a dilution of the material or medicament in the liquid and thereupon of dispensing the di¬ lution from the two-compartment syringe assembly, as will be described in greater details with reference to Figs. 2-4. Like the inner cylindri¬ cal barrel 14, the plunger 18 is also provided with two outwardly pro- truding, annular projections 102 and 104 co-operating with a circum¬ ferential recess 106 of the inner surface of the outer cylindrical wall 40 of the inner cylindrical barrel 14.
In Fig. 2, the two-compartment syringe assembly 10 is shown in a state ready for use. In this state, the inner cylindrical barrel 14 is received within the outer cylindrical barrel 12 as the first end of the inner cylindrical barrel 14 is inserted through the second, open end of the outer cylindrical barrel 12 and is locked in an extracted position as the outwardly protruding, annular projection 54 is received within the recess 38, preventing the inner cylindrical barrel 14 from being re¬ tracted from the outer cylindrical barrel 12. The dovetail-like engage¬ ment of the projection 54 within the recess 38, however, allows that the inner cylindrical barrel 14 may be advanced into the innerspace defined within the outer cylindrical barrel 12 in which the liquid 20 is en¬ closed.
In the state shown in Fig. 2, the plunger 18 is also received with¬ in the inner cylindrical barrel 14 at the second, open end thereof and is fixated relative to the inner cylindrical barrel 14 as the outwardly protruding, annular projection 102 of the plunger 18 is received within the recess 1Q6 of the inner surface of the outer cylindrical wall 40 of the inner cylindrical barrel 14. The dovetail-like engagement between the projection 102 and the recess 106 allows that the plunger 18 may be displaced into the inner space defined within the inner cylindrical bar- rel 14, however, is prevented from being retracted from the inner cy¬ lindrical barrel 14.
As is evident from Fig. 2, the plunger body 82 is in the state shown in Fig. 2 in registration with the inner space defined within the inner cylindrical wall 42 of the inner cylindrical barrel 14 and conse- quently in registration with the ampulla 16, however, arranged at a short distance from the rupturable sealing membrane 64 of the ampulla 16 which is locked in the position shown in Fig. 2 by means of the inwardly protruding, annular projections 48,50, as described above.
The material or medicament 66 enclosed within the ampulla 16 is transferred from the ampulla 16 to the liquid 20 contained within the outer cylindrical barrel 12 by pressing the plunger 18 downwardly into the inner cylindrical barrel 14 from the position or state shown in Fig. 2 to the position or state shown in Fig. 3. As the plunger 18 is moved downwardly, the cutter means 86 perforates the rupturable sealing me - brane 64 and presses the entire ampulla 16 downwardly from its position shown in Fig. 2 to the position shown in Fig. 3, i.e. beyond the inward¬ ly protruding, annular projection 48 so as to bring the rupturable, sealing membrane 62 into contact with the cutter means 52 in order to perforate the membrane 62 so as to allow the material or medicament 66 to be expelled from the ampulla 16 to the liquid 20.
As the plunger 18 is pressed downwardly from the position or state shown in Fig. 2 to the position or state shown in Fig. 3, excess air enclosed within the outer peripheral plunger wall 80 of the plunger 18 and within the outer cylindrical wall 40 of the inner cylindrical barrel 14 is vented through the through-going holes 98, the activated carbon filling 90 contained within the filter container 88 and through the apertures 94. The inner space defined within the inner cylindrical wall 42 of the inner cylindrical barrel 14 is also vented through the through-going holes 96, the combined hydrophobic filter and micropore fibre filter 100, the activated carbon filling 90 contained within the plunger body 82 and through the holes 94. Thus, any aerosols or gases liberated from the material or medicament 66, e.g. as the material or medicament is brought into contact with the liquid 20 is vented to the atmosphere, however, filtered through the combined hydrophobic filter and micropore fibre filter 100 and the activated carbon filling 90 so as to eliminate any risk that the person operating the two-compartment sy¬ ringe assembly 10 is exposed to hazardous aerosols or gases. After the material or medicament 66 is expelled from the ampulla 10 and transferred to the liquid 20, a dilution of the material or medica¬ ment within the liquid 20 is obtained by shaking the two-compartment sy¬ ringe assembly 10. Provided the outer cylindrical barrel 12 is manufac¬ tured from a material which is at least partly transparent or alterna- tively provided with a transparent window, the person operating the two- compartment syringe assembly 10 may monitor the preparation of the di¬ lution of the material or medicament within the liquid. Provided the di¬ lution is properly prepared, an injection may be performed by means of the two-compartment syringe assembly 10. It is to be emphasized that the outwardly protruding, annular pro¬ jection 104 of the outer peripheral plunger wall 80 of the plunger 18 locks within the recess 106 of the inner cylindrical surface of the outer cylindrical wall 40 of the inner cylindrical barrel 14 and pre¬ vents the plunger 18 from being retracted from the position shown in Fig. 3.
By pressing the inner cylindrical barrel 14 into the outer cylin¬ drical barrel 12 from the position or state shown in Fig. 3 to the posi¬ tion or state shown in Fig. 4, the liquid 20 having therein the material or medicament diluted is expelled or dispensed from the compartment de- fined within the outer cylindrical barrel 12 through the nozzle 28 and further through the elongated needle 34 of the needle assembly 30. The excess air present above the surface of the liquid 20 shown in Fig. 3 is vented through the combined hydrophobic filter and micropore fibre fil- ter 100 and the activated carbon filling 90 to the atmosphere. As the inner cylindrical barrel 12 is moved from the position or state shown in Fig. 3, the outwardly protruding, annular projection 54 is disengaged from its engagement within the recess 38 allowing that the inner cylin- drical barrel 14 is displaced into the inner compartment defined within the outer cylindrical barrel 12.
In the position or state shown in Fig. 4, the inner cylindrical barrel 14 is locked relative to the outer cylindrical barrel 12 as the outwardly protruding, annular projection 56 locks within the recess 38 of the inner surface of the cylindrical wall 22 of the outer cylindrical barrel 12 and prevents the inner cylindrical barrel 14 from being re¬ tracted from its position totally received within the inner compartment defined within the outer cylindrical barrel 12. Consequently, reuse of the two-compartment syringe assembly and separation of the inner cylin- drical barrel 14 from the outer cylindrical barrel is prevented. Simi¬ larly, the plunger 18 is blocked from being retracted from the inner cy¬ lindrical barrel 14 as discussed above and from being separated there¬ from.
In Fig. 5, a second embodiment of the two-compartment syringe as- sembly according to the present invention is shown, designated the re¬ ference numeral 110 in its entirety. The second embodiment 110 of the two-compartment syringe assembly according to the present invention dif¬ fers from the first, presently preferred embodiment 10 of the two-com¬ partment syringe assembly according to the present invention discussed above with reference to Figs. 1-4 in that the cutter means 52 of the in¬ ner cylindrical barrel 14 and the cutter means 86 of the plunger 18 are substituted by perforating means of a different configuration.
Furthermore, the needle assembly 30 shown in Figs. 2-4 is omitted, as the outer cylindrical barrel 12 of the two-compartment syringe as- sembly 110 shown in Fig. 5 is provided with a connector for connecting the two-compartment syringe assembly to an infusion bottle or infusion set. The connector comprises a central needle 112, which extends through the spout or nozzle 28 and is blocked at its outer, distal end in the state of storing the two-compartment syringe assembly and of preparing the dilution of the material or medicament 66 within the liquid 20 by means of a plug 114 which is biased outwardly by a helical coil 116. The assembly comprising the needle 112, the plug 114, and the coil 116 is protected by a circumferential wall 118 of the outer cylindrical barrel 12.
As an infusion bottle such as a bottle 120 shown in Fig. 5 is con¬ nected to the two-compartment syringe assembly 110, a connector plug 122 of the infusion bottle is brought into contact with the needle 112 by forcing the plug 114 upwardly or rearwardly relative to the needle 112 against the biasing force generated by the helical coil 116. After the dilution of the material 66 within the liquid 20 has been dispensed from the two-compartment syringe assembly 110 to the infusion bottle 120, the infusion bottle 120 is removed from the two-compartment syringe assembly 110 which is thereupon disposed and destructed, e.g. in a high-tempera¬ ture combustion oven of a hospital or the like. The connector plug 122 seals the infusion bottle 120 as the needle 112 is retracted from the infusion bottle.
The plug 114 serves the additional purpose of blocking the outer end of the needle 112 as the infusion bottle 120 is removed from the two-compartment syringe assembly in order to prevent that a person ope¬ rating the two-compartment syringe assembly, such as a doctor, a nurse or a pharmacist unintentionally contacts the odd end of the needle 112, which might cause serious injuries to the person, as the material or me- dicament 66 is often extremely toxic or carcinogenic, as the material or medicament 66 may constitute a cytostatic, an antibiotic, a hormone, or a central nervous agent or the like.
The cutter means 52 shown in Figs. 1-4 is substituted by an open- able four-segment cutter 124 which is shown in greater details in Fig. 5a. The four-segment cutter 124 comprises four separate, integrally cast segments, one of which is designated the reference numeral 126 which is provided with a sharp cutting edge 128 and is connected to an adjacent segment through a breakable material strip 130. The four-segment cutter 124 functions as a collapsible cutter means as the cutting edges 128 of the separate segments 126 initially perforate the rupturable, sealing membrane 62 of the ampulla 16, as the ampulla 16 is forced downwardly into contact with the four-segment cutter 124, whereupon the four seg¬ ments 126 are mutually separated along the material strips 130 and caused to hinge at the base of the individual segment 126 at the wall of the bore 46, as the material or medicament 66 is forced outwardly from the ampulla 16.
The cutter means 86 shown in Figs. 1-4 of the plunger 18 is substi¬ tuted by a protruding tip 132 which is provided centrally at the end wall of the central plunger body 82 of the plunger 18. The protruding tip 132 is c rcumferentially encircled by the through-going holes 96. As the plunger 18 is forced into the inner cylindrical barrel 12, the plunger body 82 initially forces the ampulla 16 downwardly into contact with the four-segment cutter 124, as the central plunger body 82 con¬ tacts an inner wall of an annular fixation ring 134 which prevents the membrane 64 from getting into contact with the perforating protruding tip 132. The ampulla 16 is in the second embodiment 110 of the two-com¬ partment syringe assembly according to the present invention shown in Fig. 5 maintained in a frictional surface contact established between the outer peripheral surface of the glass tube of the ampulla 16 and the inner cylindrical surface of the inner cylindrical wall 42 of the inner cylindrical barrel 14. As the plunger 18 is forced downwardly, the annu¬ lar fixation ring 134 initially forces the ampulla 16 downwardly, as discussed above, into an end position in which the lower rim of the glass tube 6 of the ampulla 16 rests behind the recess defined behind the bore 46, and further advancement of the plunger 18 causes the plunger body 82 to be forced through the annular fixation ring 134 so as to force the protruding tip 132 of the central plunger body 82 into con- tact with the rupturable sealing membrane 64 of the ampulla 16 for per¬ forating the membrane and for forcing the material or medicament 66 con¬ tained within the ampulla 16 out from the compartment defined within the ampulla 16 and down into the liquid 20.
It is to be realized that the plunger body 82 in the second embodi- ment 110 shown in Fig. 5, and also in the first embodiment 10 shown in Figs. 1-4, provides a close fit within the cyl ndrical glass tube of the ampulla 16 in order to, to any substantial extent, cause any material adhering to the inner surface of the glass tube 60 of the ampulla 16 to be forced out of the ampulla 16 as the plunger body 82 is urged into the ampulla 16.
In Fig. 6a-6e, a process of filling the ampulla 16 of the two-com¬ partment syringe assembly is shown. In Fig. 6a, the glass tube 60 is shown cut from a length of a glass tube.
In Fig. 6b, the rupturable, sealing membrane 62 is applied to the first end of the glass tube 60, e.g. by welding or by glueing the mem¬ brane 62 to the lower end of the glass tube.
In Fig. 6c, the material 66 is filled into the chamber or compart¬ ment defined within the glass tube 60 by means of a dispensing nozzle 142 in a predetermined exact amount, such as an amount of the order of 3-5 ml .
In Fig. 6d, the rupturable, sealing membrane 64 is applied to the opposite second end of the glass tube 60 for sealing the chamber or com- partment defined within the glass tube 60 of the ampulla 16. The produc¬ tion steps carried out in accordance with Fig. 6c and Fig. 6d may be carried out in a sterilized, evacuated chamber, provided the material calls for such precautions.
After the ampulla 16 has been sealed, the entire ampulla may be sterilized in a sterilizing chamber 140 shown in Fig. 6c by exposure to high-temperature treatment or high-frequency treatment, such as exposure to high-temperature steam, UV, IR or microwave radiation or the like.
In Fig. 7a-7e, a process of producing the two-compartment syringe assembly according to the present invention is shown. In Fig. 7a, the outer cylindrical barrel 12 and the inner cylindrical barrel 14 are as¬ sembled by positioning the inner cylindrical barrel 14 in the extracted position or state shown in Figs. 1, 2, 3, and 5.
In Fig. 7b, the liquid 20 which may constitute a solvent, such as an aqueous or alcoholic suspension of e.g. sugar, an acid, or a base, an electrolytic solution or the like, is dispensed from a dispensing nozzle 144 through the central passage defined within the inner cylindrical wall 40 of the inner cylindrical barrel 14.
In Fig. 7c, the sterilized ampulla 16 is introduced into the inner cylindrical barrel 14 through the upper open end thereof. In Fig. 7d, the plunger 18 is mounted as the lower first end of the plunger 18 is introduced through the upper, open end of the inner cy¬ lindrical barrel 14. The plunger is locked in the position or state shown in Figs. 1, 2, and 5. After the entire two-compartment syringe as¬ sembly 110 has been assembled, the two-compartment syringe assembly may be sterilized, e.g. in the sterilizing chamber 140 shown in Fig. 6e.
In Fig. 7e, the assembled two-compartment syringe assembly, option¬ ally sterilized, is encapsulated within a sealed plastic bag 160. After encapsulating the assembled two-compartment syringe assembly, optionally sterilized, the plastic bag 160 and the two-compartment syringe assembly 110 contained within the sealed plastic bag may be sterilized, e.g. in the sterilizing chamber 140 shown in Fig. 6e, or in a different sterili¬ zing chamber or in accordance with a different sterilizing technique. It is to be realized that the ampulla 16 may be integrated into the inner cylindrical barrel 14 of the two-compartment syringe assembly which, of course, calls for certain minor modifications of the above described processes of producing the ampulla and the two-compartment sy¬ ringe assembly. Instead of producing a separate ampulla 16 as shown in Fig. 6a-6e, the entire inner cylindrical barrel 14 is manufactured in accordance with the technique disclosed in Fig. 6a-6e, as the inner com¬ partment defined within the inner cylindrical wall 40 of the inner cy¬ lindrical barrel 14 is provided with the membrane 62 at the first, lower end of the inner cylindrical barrel 14, whereupon the material or medi- cament 66 is introduced into the inner compartment defined within the inner cylindrical barrel 14 by means of the dispensing nozzle 142. In a step corresponding to the step shown in Fig. 6d, the membrane 64 is applied to the upper, second end of the inner cylindrical barrel for sealing the inner compartment defined within the inner cylindrical wall 40 of the inner cylindrical barrel 14.
Similarly, the step shown in Fig. 7a is deleted as the l quid or solvent is dispensed from the dispensing nozzle 144 into the inner com¬ partment defined within the outer cylindrical barrel 12 prior to the step of assembling the outer cylindrical barrel 12 and the inner cylin- drical barrel 14 integrally containing the material or medicament in the inner compartment defined within the inner cylindrical barrel 14.
Example 1
A prototype implementation of the first, preferred embodiment of the two-compartment syringe assembly according to the present invention shown in Figs. 1-4 and discussed above with reference thereto was made from the following components:
The outer cylindrical barrel 12 was made from HDPE and had the fol¬ lowing dimensions. The outer diameter of the cylindrical barrel was 35 mm, the inner diameter of the cylindrical barrel was 32 mm. The inner height of the barrel was 60 mm. The outer diameter of the circumferen¬ tial flange 26 was 55 mm, and the thickness of the wall of the circumfe¬ rential flange 26 was 2 mm.
The inner cylindrical barrel 14 was made from HDPE and had the fol- lowing dimensions. The overall length of the barrel was 78 mm, the outer diameter of the barrel was 32 mm, the inner diameter of the outer cy¬ lindrical wall of the barrel was 30 mm, the length of the inner cylin¬ drical wall was 60 mm. The outer diameter of the inner cylindrical wall was 15 mm. The inner diameter of the inner cylindrical wall was 13 mm. The outer diameter of the annular flange was 38 mm. The thickness of the wall of the annular flange was 2 mm.
The ampulla 16 was made from a cylindrical glass tube of an outer diameter of 13 mm and of a wall thickness of 1 mm. The membranes were made from a laminated foil assembly comprising a 30 μm PE foil applied in contact with the rim of the glass tube and sealed thereto in a weld¬ ing process, and a 30 μm aluminum foil. The welding process was carried out by means of a pressing tool heated to a temperature of the order of 150°C-200°C which generated an excess pressure of the order of 500 g - 1.5 kg for pressing the foil assembly towards the rim of the glass tube for a period of time of the order of 0.5-1 sec. The welding process was carried out manually, during which welding process the adhesion of the laminated foil assembly to the rim of the glass tube was first tested to mechanical adherence and visually monitored.
The plunger 18 was made from HDPE. The outer diameter of the outer peripheral plunger wall was 30 mm. The wall thickness of the outer pe¬ ripheral plunger wall was .8 mm, the height of the outer peripheral plunger wall was 57 mm, and the end of the central plunger body was pro- truding 3.5 mm beyond the outer lower or opened end of the plunger. The outer diameter of the plunger body was 12 mm. The container of the plunger defined in the inner container had a diameter of 20 mm and a container height of 16 mm. The plug sealing the filter container had corresponding dimensions and was integrally cast having a wall thickness of .8 mm.
The two-compartment syringe assembly was tested as the outer cy¬ lindrical barrel 12 was filled with water, and ampullas containing NaCl and dye Green S-E 142 were manufactured. The rupturable sealing mem¬ branes of the individual ampulla were easily ruptured as the two-com- partment syringe assembly was operated as discussed above with reference to Figs. 2-4.
Example 2
The inner cylindrical barrel and the plunger of the two-compartment syringe assembly may alternatively be cast in a two-step casting process in which the cylindrical walls of the inner cylindrical barrel and the plunger are cast from HDPE, whereupon in a second, integral casting step, 0-ring sealings are cast from a more elastic thermoplastic materi- al, such as LDPE or LLDPE substituting the outwardly protruding annular projections of the inner cylindrical barrel and the plunger.
Example 3 Materials which may be of interest and relevance in connection with the two-compartment syringe assembly are: The outer cylindrical barrel, the inner cylindrical barrel, and the plunger may be cast a thermo¬ plastic material, e.g. polystyrene, polyimide, polycarbonate, polymeth- acrylates, polyvinylidenefluoride, polyamide, polyvinyl alcohol, and preferably polyolefines, such as low-density polyethylene (LDPE), medi¬ um-density polyethylene (MDPE), high-density polyethylene (HDPE), linear low-density polyethylene (LLDPE), polypropylene (PP), polypropylene- ethylene-copolymer, or any mixture thereof. The inner cylindrical wall of the inner cylindrical barrel may option- ally be plasma-coated in order to provide barrier properties by electron-ray-treatment, corona-treatment, plasma-treatment, plasma-poly¬ merisation or any other appropriate surface-treatment, for providing an integral ampulla of the inner cylindrical barrel of high-resistance, high-storage capability. The rupturable sealing membranes may be made from aluminum, laminated aluminum, such as 30 μm aluminum, which is glued and/or welded to the rim of the inner compartment defined within the inner cylindrical barrel or defined by the glass tube of the ampul¬ la. Alternatively, LDPE, PETP, or PU, optionally covered by a laminated aluminum foil, such as 30 μm LDPE, 12 μm PETP, 12 μm Al, 80 μm LDPE, may be used. Alternative laminated foil structures may be made from HIPS (high-impact polystyrene), PVOH (polyvinyl alcohol) constituting a 100% air-tight barrier in dry state, and HIPS, alternatively LDPE or PP, PVOH, and HIPS or PP, or further alternatively HDPE, PVOH, and HDPE. Another interesting and relevant foil material is PIMSP (polytri ethyl- silylpropylene).
Although the two-compartment syringe assembly and the method of producing a two-compartment syringe assembly integrally containing a solvent and a material or medicament to be dissolved in the solvent has been described with reference to specific, preferred embodiments, nu¬ merous modifications are perceivable by a person having ordinary skill in the art within the inventive concept of the present invention as de- fined in the appended patent claims. Such obvious modifications and al¬ terations of the present invention are to be construed part of the pre¬ sent invention.
List of References
10 first embodiment of two-compartment syringe assembly 12 first or outer cylindrical barrel 5 14 second or inner cylindrical barrel
16 ampulla
18 plunger
20 liquid or solvent
22 cylindrical wall 10 24 first end or dispensing end
26 circumferential flange
28 spout or nozzle
30 needle assembly
32 fixation component 15 34 needle
36 annular flange
38 recess
40 outer cylindrical wall
42 inner cylindrical wall 0 44 end wall
46 central, through-going hole
48 inwardly protruding, annular projection
50 inwardly protruding, annular projection
52 cutter means 5 54 outwardly protruding annular projection
56 outwardly protruding annular projection
60 cylindrical glass tube
62 rupturable, sealing membrane
64 rupturable, sealing membrane 0 66 material or medicament
68 circumferential score line
70 central part
72 radial score line
80 outer peripheral plunger wall 5 82 central plunger body
84 end wall
86 cutter means
88 filter container 90 activated carbon filling
92 plug body
94 venting hole
96 through-going hole 98 through-going hole
100 combined hydrophobic filter and micropore fibre filter
102 outwardly protruding, annular projection
104 outwardly protruding, annular projecction
106 recess 110 second embodiment of two-compartment syringe assembly
112 central needle
114 plug
116 helical coil
118 circumferential wall 120 infusion bottle
122 connector plug
124 four-segment cutter
126 segment
128 cutting edge 130 material strip
132 protruding tip
134 annular fixation ring
140 sterilizing chamber
142 dispensing nozzle 144 dispensing nozzle
160 sealed plastic package
I. A two-compartment syringe assembly for storing a liquid and a material and for preparing a dilution of said material within said liqu¬ id prior to dispensing said liquid, comprising: a first cylindrical barrel having a first cylindrical wall and de¬ fining a first and a second end of said first cylindrical barrel, a first compartment being defined within said first cylindrical barrel by said first cylindrical wall, said first end of said first cylindrical barrel constituting a dispensing end and said second end of said first cylindrical barrel being open, a second cyl ndrical barrel having an outer cylindrical wall, an inner cylindrical wall, and an end wall and defining a first and a se- cond end of said second cylindrical barrel, said outer and inner cylin¬ drical walls being integrally connected through said end wall at said first end of said second cylindrical barrel, a second compartment being defined within said second cylindrical barrel by said inner cylindrical wall of said second cylindrical barrel and constituting a sealed com- partment sealed by rupturable seals provided at said first and second ends of said second cylindrical barrel, a plunger having a central plunger body and an outer peripheral plunger wall circumferentially encircling said central plunger body, said liquid being received within said first compartment of said first cylindrical barrel, and said material being enclosed within said second compartment of said second cylindrical barrel, said plunger being inserted into said second cylindrical barrel through said second end thereof, having its plunger body registered re- lative to said inner cylindrical wall of said second cylindrical barrel, and having its outer peripheral plunger wall received within said outer cylindrical wall of said second cylindrical barrel, said plunger being axially displaceable relative to said second cy¬ lindrical barrel from a first, extracted position to a second, inserted position in which said plunger body of said plunger is inserted into said second compartment of said second cylindrical barrel through said second end thereof, having ruptured said rupturable seals at said first and second ends of said second cylindrical barrel, and establishes a

Claims

sealing relationship with said inner cylindrical wall of said second cy¬ lindrical barrel, so as to allow said material to be dispensed from said second compartment to said first compartment for being diluted within said liquid, said second cylindrical barrel being inserted into said first cy¬ lindrical barrel through said second end thereof, having its first end received within said first compartment, said second cylindrical barrel being axially displaceable relative to said first cylindrical barrel in sealing relationship therewith from a third, extracted position to a fourth position in which said first compartment is substantially diminished and said liquid is dispensed from said first cylindrical barrel through said first end thereof.
2. The two-compartment syringe assembly according to Claim 1, said plunger defining a venting passage extending through said plunger body, in which venting passage a filtering means is enclosed.
3. The two-compartment syringe assembly according to Claim 2, said filtering means comprising a hydrophobic filter means, such as a foil of micropore polyurethane (PU), micropore polytetrafluoroethylene (PTFE), micropore polypropylene (PP) or micropore polyethylene (PE), a micropore fibre filter, and an activated carbon filter body.
4. The two-compartment syringe assembly according to any of the Claims 1-3, further comprising a first, breakable locking means for locking said plunger in said first, extracted position relative to said second cylindrical barrel.
5. The two-compartment syringe assembly according to any of the Claims 1-4, further comprising a second locking means for locking said plunger in said second, inserted position relative to said second cy¬ lindrical barrel when displaced to said second, inserted position from said first, extracted position and for preventing said plunger from be- ing retracted from said second, inserted position relative to said se¬ cond cylindrical barrel.
6. The two-compartment syringe assembly according to any of the Claims 1-5, further comprising a third, breakable locking means for locking said second cylindrical barrel in said third, extracted position relative to said first cylindrical barrel.
7. The two-compartment syringe assembly according to any of the Claims 1-6, further comprising a fourth locking means for locking said second cylindrical barrel in said fourth position relative to said first cylindrical barrel when displaced to said fourth position from said third, extracted position and for preventing said second cylindrical barrel from being retracted from said fourth position relative to said first cyl ndrical barrel.
8. The two-compartment syringe assembly according to any of the Claims 1-7, said first cylindrical barrel being made from a thermoplastic material, e.g. polystyrene, polyimide, polycarbonate, po- lymethacrylates, polyvinylidenefluoride, polyamide, polyvinyl alcohol, and preferably polyolefines, such as low-density polyethylene (LDPE), med um-density polyethylene (MDPE), high-density polyethylene (HDPE), linear low-density polyethylene (LLDPE), polypropylene (PP), polypropy¬ lene-ethylene-copolymer, or any mixture thereof.
9. The two-compartment syringe assembly according to any of the Claims 1-8, said the second cylindrical barrel being made from a thermoplastic material, e.g. polystyrene, polyimide, polycarbonate, po- lymethacrylates, polyvinylidenefluoride, polyamide, polyvinyl alcohol, and preferably polyolefines, such as low-density polyethylene (LDPE), medium-density polyethylene (MDPE), high-density polyethylene (HDPE), linear low-density polyethylene (LLDPE), polypropylene (PP), polypropy- lene-ethylene-copolymer, or any mixture thereof.
10. The two-compartment syringe assembly according to Claim 9, said inner cylindrical wall of said second cylindrical barrel being made from a material which has been surface-treated in order to provide barrier properties by electron-ray-treatment, corona-treatment, plasma-treat- ment, plasma-polymerisation or any other appropriate surface-treatment.
11. The two-compartment syringe assembly according to any of the Claims 1-10, said plunger being made from a thermoplastic material, e.g. polystyrene, polyimide, polycarbonate, polymethacrylates, polyvinyli- denefluoride, polyamide, polyvinyl alcohol, and preferably polyolefines, such as low-density polyethylene (LDPE), medium-density polyethylene (MDPE), high-density polyethylene (HDPE), linear low-density polyethyl¬ ene (LLDPE), polypropylene (PP), polypropylene-ethylene-copolymer, or any mixture thereof.
12. The two-compartment syringe assembly according to any of the Claims 1-11, said second cylindrical barrel being composed of an outer body part and a capsule part, said capsule part comprising said inner cylindrical wall and said rupturable seal , and said outer body part constituting a support structure having a central recess in which said capsule part is received.
13. The two-compartment syringe assembly according to Claim 12, said capsule part constituting a prefilled, sterilized ampulla.
14. The two-compartment syringe assembly according to Claim 12 or 13, said capsule part comprising a cylindrical glass tube having oppo¬ site ends at which said rupturable seals are fixated relative to said cylindrical glass tube.
15. The two-compartment syringe assembly according to any of the Claims 1-14, said rupturable seals being made from a foil of a plastic material, e.g. a foil of LDPE, LLDPE, MDPE, HDPE, PP, PU, copolymers and laminates thereof, a foil of aluminum, or a laminated multilayer combi¬ nation thereof.
16. The two-compartment syringe assembly according to Claim 15, said rupturable seals being provided with score lines.
17. The two-compartment syringe assembly according to any of the Claims 1-16, said liquid being a solvent, an alcoholic or aqueous solu¬ tion, base, acid, saline or sugary solution or the like, or any combina¬ tion thereof.
18. The two-compartment syringe assembly according to any of the Claims 1-17, said material being a highly active or aggressive material, such as pharmaceuticals, e.g. cytostatics, anti-biotics, hormones, cen¬ tral nervous agents, vaccines, anti-dotes, anti-bodies, anti-allergic agents, anti-coagulants, aggressive solutions, such as acids, bases, electrolytic solutions, solvents, such as DMSO (dimethylenesulphoxide), or any other materials or medicaments to be stored in a separate con¬ tainer, e.g. in a non-aqueous environment or in a highly concentrated solution.
19. The two-compartment syringe assembly according to any of the Claims 1-18, further comprising a first seal-breaking means provided at said first end of said second cylindrical barrel for breaking said rup¬ turable seal at said first end of said second cylindrical barrel when said plunger is displaced axially relative to said second cylindrical barrel from said first, extracted position towards said second, inserted position.
20. The two-part component syringe assembly according to the Claims 12 or 13 and 19, said first seal-breaking means being constituted by a cutting means provided at said support structure for perforating said rupturable seal as said capsule part is displaced within said central recess of said outer body part from a fifth, retracted position in which said rupturable seal provided at said first end of said second cylin¬ drical barrel is out of contact with said first seal-breaking means and into a sixth position in which said rupturable seal provided at said first end of said second cylindrical barrel is brought into contact with said first seal-breaking means through impact from said plunger agita¬ ting said capsule part.
21. The two-compartment syringe assembly according to any of the Claims 1-20, further comprising a second seal-breaking means provided at said plunger body of said plunger for breaking said rupturable seal at said second end of said second cylindrical barrel when said plunger is displaced axially relative to said second cylindrical barrel from said first, extracted position towards said second, inserted position.
22. A method of producing a two-compartment syringe assembly for storing a liquid and a material and for preparing a dilution of said ma¬ terial within said liquid prior to dispensing said liquid, comprising the steps of providing a first cylindrical barrel having a first cylindrical wall and defining a first and a second end of said first cylindrical barrel, a first compartment being defined within said first cylindrical barrel by said first cylindrical wall, said first end of said first cy¬ lindrical barrel constituting a dispensing end and said second end of said first cylindrical barrel being open, providing a second cylindrical barrel having an outer cylindrical wall, an inner cylindrical wall, and an end wall and defining a first and a second end of said second cylindrical barrel, said outer and inner cylindrical walls being integrally connected through said end wall at said first end of said second cylindrical barrel, a second compartment being defined within said second cylindrical barrel by said inner cy- l ndrical wall of said second cylindrical barrel and constituting a sealed compartment sealed by rupturable seals provided at said first and second ends of said second cylindrical barrel, providing a plunger having a central plunger body and an outer pe¬ ripheral plunger wall circumferentially encircling said central plunger body, arranging said liquid being received within said first compartment of said first cylindrical barrel, arranging said material being enclosed within said second com- partment of said second cylindrical barrel, inserting said plunger into said second cylindrical barrel through said second end thereof, having its plunger body registered relative to said inner cylindrical wall of said second cylindrical barrel, and ha- ving its outer peripheral plunger wall received within said outer cy¬ lindrical wall of said second cylindrical barrel, so that said plunger is axially displaceable relative to said second cylindrical barrel from a first, extracted position to a second, inserted position in which said plunger body of said plunger is inserted into said second compartment of said second cylindrical barrel through said second end thereof, having ruptured said rupturable seals at said first and second ends of said se¬ cond cylindrical barrel, and establishes a sealing relationship with said inner cylindrical wall of said second cylindrical barrel, so as to allow said material to be dispensed from said second compartment to said first compartment for being diluted within said liquid, and inserting said second cylindrical barrel into said first cy¬ lindrical barrel through said second end thereof, having its first end received within said first compartment, so that said second cylindrical barrel is axially displaceable relative to said first cylindrical barrel in sealing relationship therewith from a third, extracted position to a fourth position in which said first compartment is substantially di¬ minished and said liquid is dispensed from said first cylindrical barrel through said first end thereof.
23. The method according to Claim 22, said first and second cylin- drical barrels, said plunger, said liquid, and said material having any of the characteristics of the two-compartment syringe assembly according to any of the Claims 1-20.
24. The method according to any of the Claims 22-23, further com¬ prising the introductory step of producing said second cylindrical bar- rel as a combination of an outer body part and a capsule part, said cap¬ sule part comprising said inner cylindrical wall and said rupturable seals, and said outer body part constituting a support structure having a central recess in which said capsule part is received, and of ar¬ ranging said material enclosed within said capsule part.
PCT/DK1991/000380 1990-12-04 1991-12-04 A two-compartment syringe assembly and a method of producing a two-compartment syringe assembly WO1992010225A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US07/781,220 US5429603A (en) 1990-12-04 1991-12-04 Two-compartment syringe assembly and a method of producing a two-compartment syringe assembly

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK288590A DK288590D0 (en) 1990-12-04 1990-12-04 MIXTURE / SOLUTION SPRAY FOR CYTOSTATICS FOR MEDICAL TREATMENT OF CANCER PATIENTS
DK2885/90 1990-12-04

Publications (1)

Publication Number Publication Date
WO1992010225A1 true WO1992010225A1 (en) 1992-06-25

Family

ID=8116788

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/DK1991/000380 WO1992010225A1 (en) 1990-12-04 1991-12-04 A two-compartment syringe assembly and a method of producing a two-compartment syringe assembly

Country Status (5)

Country Link
US (1) US5429603A (en)
EP (1) EP0560831A1 (en)
AU (1) AU9027491A (en)
DK (1) DK288590D0 (en)
WO (1) WO1992010225A1 (en)

Cited By (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330426A (en) * 1992-08-13 1994-07-19 Science Incorporated Mixing and delivery syringe assembly
WO1996029106A2 (en) * 1995-03-22 1996-09-26 Abbott Laboratories Pre-filled syringe drug delivery system
EP0734737A2 (en) * 1993-04-08 1996-10-02 Oxford BioSciences Limited Particle delivery of particularly therapeutic powdered agents
US5779668A (en) * 1995-03-29 1998-07-14 Abbott Laboratories Syringe barrel for lyophilization, reconstitution and administration
US5876372A (en) * 1995-03-22 1999-03-02 Abbott Laboratories Syringe system accomodating seperate prefilled barrels for two constituents
NL1007544C2 (en) * 1996-11-13 2000-08-01 Astra Ab Membrane.
US8015969B2 (en) * 2007-09-18 2011-09-13 Robert Abrams Semi-automatic emergency medication dose nebulizer
US8061006B2 (en) 2001-07-26 2011-11-22 Powderject Research Limited Particle cassette, method and kit therefor
WO2012104376A1 (en) * 2011-02-02 2012-08-09 Bioneer A/S A syringe
US8291902B2 (en) 2007-09-18 2012-10-23 Robert Abrams Enhanced semi-automatic emergency medication dose nebulizer
EP2640526A1 (en) * 2010-11-18 2013-09-25 Biolyph, Llc Reagent preparation and dispensing device
US8940539B2 (en) 2008-05-14 2015-01-27 Biolyph, L.L.C. Reagent preparation and dispensing device and methods for the same
US8973749B2 (en) 2010-06-29 2015-03-10 Biolyph, L.L.C. Reagent preparation assembly
EP2424596A4 (en) * 2009-04-30 2018-03-28 Hyperbranch Medical Technology, Inc. Applicator system for the delivery of surgical sealants

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6796966B2 (en) * 1997-10-15 2004-09-28 Jeffrey E. Thomas Apparatus, and kits for preventing of alleviating vasoconstriction or vasospasm in a mammal
DE19749514A1 (en) * 1997-11-08 1999-05-12 Pfeiffer Erich Gmbh & Co Kg Delivery of a mixture of media for e.g. pharmaceutical products
US6019750A (en) 1997-12-04 2000-02-01 Baxter International Inc. Sliding reconstitution device with seal
AR021220A1 (en) 1998-09-15 2002-07-03 Baxter Int CONNECTION DEVICE FOR ESTABLISHING A FLUID COMMUNICATION BETWEEN A FIRST CONTAINER AND A SECOND CONTAINER.
US20050137566A1 (en) 2003-12-23 2005-06-23 Fowles Thomas A. Sliding reconstitution device for a diluent container
US6022339A (en) 1998-09-15 2000-02-08 Baxter International Inc. Sliding reconstitution device for a diluent container
US6527738B1 (en) 1999-04-30 2003-03-04 Prismedical Corporation Drug delivery pack
WO2001000261A1 (en) * 1999-06-30 2001-01-04 Baxter International Inc. Syringe for transfer of medication from a prefilled medication container
US6428505B1 (en) * 1999-11-19 2002-08-06 Prismedical Corporation In-line IV drug delivery pack with controllable dilution
DE10006474A1 (en) * 2000-02-14 2001-08-16 Transcoject Gmbh Filling syringe for medical and other purposes, comprises removal of gas (mixture) from the syringe cylinder through hole in the piston face and subsequent plugging of this hole
GB0020080D0 (en) * 2000-08-15 2000-10-04 Borealis Tech Oy Injection moulding
US6770052B2 (en) * 2000-10-10 2004-08-03 Meridian Medical Technologies, Inc. Wet/dry automatic injector assembly
US7621887B2 (en) * 2000-10-10 2009-11-24 Meridian Medical Technologies, Inc. Wet/dry automatic injector assembly
US6641561B1 (en) 2000-10-10 2003-11-04 Meridian Medical Technologies, Inc. Drug delivery device
US7556614B2 (en) * 2000-10-10 2009-07-07 Meridian Medical Technologies, Inc. Separation assembly for drug delivery device
US7544189B2 (en) * 2000-10-10 2009-06-09 Meridian Medical Technologies, Inc. Needle and hub assembly for automatic injector
WO2002067778A2 (en) * 2001-02-26 2002-09-06 Ben-Ami Ballin Syringe for use in blood analysis
ATE376434T1 (en) * 2001-04-21 2007-11-15 Curevac Gmbh INJECTION DEVICE FOR MRNA APPLICATION
US6878338B2 (en) 2001-05-04 2005-04-12 Prismedical Corporation Dual chamber dissolution container with passive agitation
DE10242984B4 (en) * 2002-09-17 2010-09-23 Sanatis Gmbh Device for producing mixtures of two components
US7135027B2 (en) * 2002-10-04 2006-11-14 Baxter International, Inc. Devices and methods for mixing and extruding medically useful compositions
WO2004110512A2 (en) * 2003-06-12 2004-12-23 Interface Biotech A/S A method for cell implantation
US7641851B2 (en) 2003-12-23 2010-01-05 Baxter International Inc. Method and apparatus for validation of sterilization process
US7329235B2 (en) * 2004-08-02 2008-02-12 Bertron Kim W Powder and liquid mixing syringe
AT500930B1 (en) * 2004-10-25 2007-03-15 Pharma Consult Ges M B H & Co METHOD AND DEVICE FOR LYOPHILIZING, RECONSTITUTING AND DISTRIBUTING A RECONSTITUTED ACTIVE SUBSTANCE
US20060144869A1 (en) * 2004-12-30 2006-07-06 Chang Byeong S Container closure delivery system
US7959600B2 (en) 2004-12-30 2011-06-14 Byeong S. Chang Container closure delivery system
ITVI20050152A1 (en) * 2005-05-20 2006-11-21 Tecres Spa CARTRIDGE FOR CONSERVATION AND STERILE DISTRIBUTION OF A BIPHASIC COMPOUND, PARTICULARLY FOR AN ACRYLIC RESIN
WO2006128915A1 (en) * 2005-06-02 2006-12-07 Schwoebel Eckhard Multi-cylinder syringe
WO2007038773A1 (en) * 2005-09-28 2007-04-05 Biodel, Inc. Self-filling two chamber injectable device
EP1945559B1 (en) * 2005-10-14 2018-05-30 3M Innovative Properties Company Plunger and plunger assembly for a cartridge, system for storing a substance, and method of filling and sealing a substance in a delivery system
US20070092451A1 (en) 2005-10-25 2007-04-26 Loveridge Dan E Time indicating containers for dental compositions
US20070183986A1 (en) * 2006-02-06 2007-08-09 Ultradent Products, Inc. Methods and systems for mixing a multi-part fluoride varnish composition
US20080114307A1 (en) * 2006-11-06 2008-05-15 Jeffrey Smith Puncturable membrane for safety syringe
US20070255204A1 (en) * 2006-05-01 2007-11-01 Ultradent Products, Inc Time-indicating syringe mixing devices and related methods for storing and dispensing two-part dental compositions
US7776010B2 (en) * 2006-05-01 2010-08-17 Ultradent Products, Inc. Syringe-in-syringe hollow inner barrel/plunger with integral seal and rupturable membrane and related kits, systems, and methods
WO2008051925A2 (en) * 2006-10-23 2008-05-02 Sibbitt Wilmer L Jr Reciprocating mixing syringes
US8454558B2 (en) * 2007-02-09 2013-06-04 Ultradent Products, Inc. Syringe-in-syringe hollow inner barrel/plunger with integral seal and rupturable membrane and related kits, systems and methods
US8256949B2 (en) * 2007-12-27 2012-09-04 Cook Medical Technologies Llc Apparatus and method for mixing and dispensing a bone cement mixture
US8383163B2 (en) * 2008-01-29 2013-02-26 Ultradent Products, Inc. Fluoride varnish compositions including an organo phosphoric acid adhesion promoting agent
US20100100099A1 (en) * 2008-06-24 2010-04-22 Tayla Reilly Curable material transfer and delivery device
EP2361107B1 (en) * 2008-09-10 2019-02-20 Thomasevans, Llc Multi-chambered mixing syringe device and methods of use
US20100114057A1 (en) * 2008-10-31 2010-05-06 Medtronic, Inc. System and method for delivery of biologic agents
ITAR20090017A1 (en) * 2009-03-23 2010-09-24 Nedo Magrini SYRINGE, PARTICULARLY FOR MEDICAL AND VETERINARY USE, MULTICAMERA, SINGLE USE AND PRE-LOADED
IL197761A0 (en) * 2009-03-23 2009-12-24 Moshe Zalsman Capsule for mixing together two flowable materials, and kits including such capsules, particularly useful in dentistry
US20100247671A1 (en) 2009-03-26 2010-09-30 Thomas Jeffrey E Method and composition for alleviating or preventing ischemic tissue damage
DE102009040783B4 (en) * 2009-09-09 2012-04-26 F. Holzer Gmbh Metering device for metered dispensing of liquid preparations, method for filling and use of a metering device according to the invention
US20120041388A1 (en) * 2010-08-11 2012-02-16 Farnam Companies, Inc. Syringe handle device
EP2663275B1 (en) 2011-01-10 2017-03-08 Byeong Seon Chang Compact medication reconstitution device and method
EP3854433A3 (en) 2011-11-07 2021-10-27 Battelle Memorial Institute Processes for delivery of viscous drug therapies
US10201692B2 (en) 2014-09-09 2019-02-12 Byeong Seon Chang Solution delivery device and method
EP3025744A1 (en) 2014-11-28 2016-06-01 Sulzer Mixpac AG Apparatus and methods for storing and mixing separate substances
CN107734982B (en) * 2015-06-29 2021-07-13 菲利普莫里斯生产公司 Cartridge and device for an aerosol-generating system
EP3299082A1 (en) 2016-09-21 2018-03-28 3M Innovative Properties Company Mixer assembly and device for dispensing a dental material
DE102016121607B4 (en) * 2016-11-11 2019-05-16 Heraeus Medical Gmbh Apparatus and method for storing and mixing a bone cement
EP4096577B1 (en) * 2020-01-27 2023-12-27 Carl Zeiss Meditec AG Injector assembly for inserting an intraocular lens

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3327710A (en) * 1963-11-15 1967-06-27 Santo John De Combination hypodermic syringe and mixing container
US3477432A (en) * 1964-07-21 1969-11-11 Joseph Denman Shaw Combination mixing and injecting medical syringe
GB1313339A (en) * 1969-09-09 1973-04-11 Minnesota Mining & Mfg Combination mixing capsule and dispenser
US3890971A (en) * 1973-10-23 1975-06-24 Thomas A Leeson Safety syringe
DE3618318C2 (en) * 1986-05-30 1988-04-14 Roland Dr.Med. 7614 Gengenbach De Rau
EP0397589A1 (en) * 1989-05-12 1990-11-14 Wolff & Kaaber A/S A method and device for preparing a mixture of a solid and a liquid component

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1503219A (en) * 1923-02-09 1924-07-29 John H Wedig Hypoampul syringe
US2778360A (en) * 1955-05-09 1957-01-22 Pfizer & Co C Hypodermic syringe
BE563608A (en) * 1957-01-03
NL293244A (en) * 1962-05-29
US3557787A (en) * 1968-05-28 1971-01-26 Milton J Cohen Disposable syringe
US3570486A (en) * 1968-10-14 1971-03-16 Horizon Ind Ltd Mixing syringe
US3685514A (en) * 1969-09-23 1972-08-22 Paul E Cheney Two compartment syringe
US3831742A (en) * 1972-10-16 1974-08-27 Pennwalt Corp Dental mixing capsule
CH622752A5 (en) * 1978-01-10 1981-04-30 Sulzer Ag Container for the storage of the powder component of a bone cement
DE2838222A1 (en) * 1978-08-30 1980-03-13 Galia Karl Sterile mixing of powder with fluid - by fluid ampoule inserted in flexible powder bag with burst membrane
US4254768A (en) * 1979-09-14 1981-03-10 Ty Perla J Hypodermic syringe
US4306554A (en) * 1980-08-27 1981-12-22 Boris Schwartz Isolation storage and intermixing syringe for medicants
US4463875A (en) * 1982-06-14 1984-08-07 Robert W. Mann Method and apparatus for preparing and applying a two-component cement
US4464174A (en) * 1982-09-27 1984-08-07 Silver Industries, Inc. Two compartment mixing syringe seal
US4546767A (en) * 1983-10-27 1985-10-15 Smith Carl W Cement injection device
EP0229754B1 (en) * 1985-05-14 1990-05-02 Ao-Forschungsinstitut Davos Method and apparatus for preparaing a self-curing two component powder/liquid cement
US4693706A (en) * 1986-08-11 1987-09-15 Mark L. Anderson Two compartment mixing syringe
US4886495A (en) * 1987-07-08 1989-12-12 Duoject Medical Systems Inc. Vial-based prefilled syringe system for one or two component medicaments
SE464797B (en) * 1988-04-15 1991-06-17 Kabi Pharmacia Ab Device for preparing an injection solution
US4768568A (en) * 1987-07-07 1988-09-06 Survival Technology, Inc. Hazardous material vial apparatus providing expansible sealed and filter vented chambers
US4910259A (en) * 1988-09-26 1990-03-20 Wolff & Kaaber A/S Bone cement

Patent Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3327710A (en) * 1963-11-15 1967-06-27 Santo John De Combination hypodermic syringe and mixing container
US3477432A (en) * 1964-07-21 1969-11-11 Joseph Denman Shaw Combination mixing and injecting medical syringe
GB1313339A (en) * 1969-09-09 1973-04-11 Minnesota Mining & Mfg Combination mixing capsule and dispenser
US3890971A (en) * 1973-10-23 1975-06-24 Thomas A Leeson Safety syringe
DE3618318C2 (en) * 1986-05-30 1988-04-14 Roland Dr.Med. 7614 Gengenbach De Rau
EP0397589A1 (en) * 1989-05-12 1990-11-14 Wolff & Kaaber A/S A method and device for preparing a mixture of a solid and a liquid component

Cited By (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0756506A1 (en) * 1992-08-13 1997-02-05 Science Incorporated Mixing and delivery syringe assembly
EP0756506A4 (en) * 1992-08-13 1998-05-06 Science Inc Mixing and delivery syringe assembly
US5330426A (en) * 1992-08-13 1994-07-19 Science Incorporated Mixing and delivery syringe assembly
US6881200B2 (en) 1993-04-08 2005-04-19 Powderject Research Limited Needleless syringe using super sonic gas flow for particle delivery
EP0734737A2 (en) * 1993-04-08 1996-10-02 Oxford BioSciences Limited Particle delivery of particularly therapeutic powdered agents
EP0734737A3 (en) * 1993-04-08 1997-03-12 Oxford Biosciences Ltd Particle delivery of particularly therapeutic powdered agents
US7942846B2 (en) * 1993-04-08 2011-05-17 Powderject Research Limited Needleless syringe using supersonic gas flow for particle delivery
US7618394B2 (en) 1993-04-08 2009-11-17 Powderject Research Limited Needleless syringe using supersonic gas flow for particle delivery
WO1996029106A2 (en) * 1995-03-22 1996-09-26 Abbott Laboratories Pre-filled syringe drug delivery system
WO1996029106A3 (en) * 1995-03-22 1996-10-24 Abbott Lab Pre-filled syringe drug delivery system
AU696759B2 (en) * 1995-03-22 1998-09-17 Abbott Laboratories Pre-filled syringe drug delivery system
US5876372A (en) * 1995-03-22 1999-03-02 Abbott Laboratories Syringe system accomodating seperate prefilled barrels for two constituents
US5779668A (en) * 1995-03-29 1998-07-14 Abbott Laboratories Syringe barrel for lyophilization, reconstitution and administration
BE1012530A5 (en) * 1996-11-13 2000-12-05 Astra Aktieboalg Membrane.
NL1007544C2 (en) * 1996-11-13 2000-08-01 Astra Ab Membrane.
US8061006B2 (en) 2001-07-26 2011-11-22 Powderject Research Limited Particle cassette, method and kit therefor
US8015969B2 (en) * 2007-09-18 2011-09-13 Robert Abrams Semi-automatic emergency medication dose nebulizer
US8291902B2 (en) 2007-09-18 2012-10-23 Robert Abrams Enhanced semi-automatic emergency medication dose nebulizer
US8940539B2 (en) 2008-05-14 2015-01-27 Biolyph, L.L.C. Reagent preparation and dispensing device and methods for the same
EP2424596A4 (en) * 2009-04-30 2018-03-28 Hyperbranch Medical Technology, Inc. Applicator system for the delivery of surgical sealants
US11819852B2 (en) 2010-06-29 2023-11-21 Biolyph, Llc Reagent preparation assembly
US10668473B2 (en) 2010-06-29 2020-06-02 Biolyph, Llc Reagent preparation assembly
US10406524B2 (en) 2010-06-29 2019-09-10 Biolyph, Llc Reagent preparation assembly
US8973749B2 (en) 2010-06-29 2015-03-10 Biolyph, L.L.C. Reagent preparation assembly
US9889442B2 (en) 2010-11-18 2018-02-13 Biolyph, L.L.C. Reagent preparation and dispensing device
EP3147032A1 (en) * 2010-11-18 2017-03-29 Biolyph, Llc Reagent preparation and dispensing device
US8919390B2 (en) 2010-11-18 2014-12-30 Biolyph, L.L.C. Reagent preparation and dispensing device
EP2640526A4 (en) * 2010-11-18 2014-06-04 Biolyph Llc Reagent preparation and dispensing device
EP2640526A1 (en) * 2010-11-18 2013-09-25 Biolyph, Llc Reagent preparation and dispensing device
US9937295B2 (en) 2011-02-02 2018-04-10 Bioneer A/S Syringe for mixing and ejecting an active pharmaceutical ingredient
WO2012104376A1 (en) * 2011-02-02 2012-08-09 Bioneer A/S A syringe

Also Published As

Publication number Publication date
EP0560831A1 (en) 1993-09-22
DK288590D0 (en) 1990-12-04
AU9027491A (en) 1992-07-08
US5429603A (en) 1995-07-04

Similar Documents

Publication Publication Date Title
WO1992010225A1 (en) A two-compartment syringe assembly and a method of producing a two-compartment syringe assembly
JP6743076B2 (en) cartridge
US5533994A (en) Storage and transfer bottle designed for storing two components of a medicamental substance
CA1053527A (en) Two-chamber mixing syringe
US5114421A (en) Medicament container/dispenser assembly
RU2384349C2 (en) Method and devices for lyophilisation, reconstitution and introduction of reconstituted reactant
US6840291B2 (en) Attachment for a medical device
EP1323447B1 (en) Retracting needle syringe
CA2315898C (en) Method of making a retracting needle syringe
SK102695A3 (en) Prefilled syringe for storing and dispensing of liquid and sterile drugs
JPH0638835B2 (en) Hazardous substance vial device and method
US4401432A (en) Storage, mixing and filtering receptacle for syringe
JPH0531189A (en) 2-chamber type injector
SK22896A3 (en) Device for the preparation of a solution, a suspension or an emulsion of medicinal substance
WO1997020536A1 (en) Device for preparing a medicinal solution reconstituted from two components
CA2588861A1 (en) Novel device
JP3404177B2 (en) Infusion container
JP3128755B2 (en) Infusion container for infusion
JPH10151175A (en) Infusion container for instillation
CA2170310A1 (en) Dual chamber internal by-pass syringe assembly
JPH09201396A (en) Drug dissolving kit and drug dissolving and injection system
JPH05329192A (en) Liquid transfusion container

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AT AU BB BG BR CA CH DE DK ES FI GB HU JP KP KR LK LU MG MW NL NO PL RO SD SE SU US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE BF BJ CF CG CH CI CM DE DK ES FR GA GB GN GR IT LU MC ML MR NL SE SN TD TG

DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 1992900054

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1992900054

Country of ref document: EP

REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: CA

WWW Wipo information: withdrawn in national office

Ref document number: 1992900054

Country of ref document: EP